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1. Introduction 
1.1. Principles of bacteria-host interactions and microbial virulence 
Every mammalian organism interacts with a broad variety of microorganisms such as 
fungi and bacteria (Zasloff, 2002). Most of these interactions are symbiotic or commensal in 
nature and in these relationships, the host microorganism population is usually referred to 
as microflora (Tlaskalova-Hogenova et al., 2004). Host microflora plays an important role in 
maintaining body homeostasis and contributes to the natural resistance of the host to other 
types of infection (Berg, 1996).  
In other cases, some microorganisms can be pathogenic to the host organism. Their 
pathogenic properties can compromise host immunity and result in the development of 
disease. The specific clinical outcomes of many infectious diseases are determined by the 
broad spectrum of host-pathogen interactions.   
Host-pathogen interactions describe infectious processes that include the interplay 
between microorganism virulence factors and the response mechanisms of host defense 
(Casadevall and Pirofski, 2000).  
To understand the concept of host-pathogen interaction the terms bacterial virulence 
and pathogenicity must also be understood. Virulence is defined as the relative capacity of a 
pathogen to overcome the host immune response and is determined by a particular set of  
bacteria virulence factors (Sparling, 1983). Common bacterial virulence factors include 
toxins, enzymes, antigens, invasins and adhesins. Virulence factors modulate different steps 
of infection such as attachment, proliferation, tissue damage, invasion and intracellular 
persistence of the pathogen. The summarized effects of virulence factors result in the 
development of disease and are categorized by bacteria pathogenicity (Casadevall and 
Pirofski, 1999).  
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Figure 1. The model of host-pathogen interaction (Casadevall and Pirofski, 2000).  
After initial invasion microorganisms have developed several strategies corresponding to disease development 
and level of the damage to the host. Single-headed arrows indicate: A, commensal state causing no damage to 
the host; B and C, initial colonization with gradually growing damage with subsequent elimination of infection; 
D, E and F, disease development as result of impaired immune system, state of colonization or initial pathogen 
virulence; G, result of colonization and inability of immune the system to eradicate pathogen is chronicity and 
latency of pathogen persistence; H, persistent infection reactivation leads to disease or disease silencing to 
persistence development; I and J, major outcomes of infection disease – death as result of irreversible damage 
to the host or therapeutic eradication of pathogen with reversible or irreversible host organism damage. The 
various states are shown in the figures of damage/time dependency. Double-headed arrows stand for 
conditions of variable amounts of damage.     
 
Bacteria pathogenicity can be described based on the parameters of pathogen-induced 
host damage. Theoretically, overall damage to the host can occur directly via the pathogen 
or indirectly via pathogen-induced hyperactivation of the host defense mechanism. 
Infections with weak host immune response and serious infection outcomes usually refer to 
pathogen-mediated damage, while strong host immune response refers to host-mediated 
damage. Therefore, the outcome of a particular disease largely depends on host reactivity 
and/or direct capability of the pathogen to destroy cells or tissue. As a result, many 
parameters including the structure and functions of the host might be altered (Casadevall 
and Pirofski, 1999) (Fig. 1).  
Taking into account the concepts mentioned above, this study will focus on endothelium-
S. aureus infections as a particular example of host-pathogen interaction.  
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1.2. Staphylococcus aureus 
More than 20 species of Staphylococcus are known (Garrity, 2004 ), but the most 
prominent human pathogen among them is Staphylococcus aureus. First recorded by 
Rosenbach in 1884, S. aureus was described as type of bacteria forming yellow colonies. The 
taxonomic classification of S. aureus places it as part of the genus Staphylococcus in the 
bacterial family Staphylococcaceae (Micrococcaceae) (Todar, 2008-2012 ).  
S. aureus are gram-positive spherical cocci approximately 1 µm in diameter that form 
grape-like clusters. This characteristic growth can be explained by cell division occurring in 
three perpendicular planes without sister cell detachment (Todar, 2008-2012 ). 
The majority of bacterial strains show hemolytic properties on blood agar. In metabolic 
terms, S. aureus are facultative anaerobes, catalase-positive, oxidase-negative bacteria and 
the majority of documented strains are coagulase-positive.  
 
1.2.1. S. aureus is a human pathogen 
S. aureus mainly colonizes the nasal-pharyngeal passages of healthy carriers, but it can 
also be regularly found at other locations including the skin, oral cavity and gastrointestinal 
tract (Todar, 2008-2012 ). About 30% of healthy individuals carry S. aureus persistently and 
up to 70% carry it transiently. This high level of transport can be partly explained by S. 
aureus’ adherent properties to human mucosa surfaces through a number of surface 
adhesins that include can, fnbpa, fnbpb, eap etc. Variability and redundancy of S. aureus 
adhesins allow attachment to multiple cell types, such as platelets, epithelial and 
endothelial cells, phagocytes as well as different extracellular matrix proteins (Jefferson, 
2009  ). 
Due to broad range of virulence factors including adhesins,  S. aureus has been reported 
to cause a spectrum of varying infections ranging from minor skin boils to severe life-
threatening diseases such as septic shock or endocarditis (Lowy, 1998). Several host factors 
have been reported to  predispose staphylococcal infection: diabetes mellitus, use of 
intravenous catheters, drug abuse, AIDS, etc. (Archer, 1998). 
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1.2.2. Antibiotic resistance of S. aureus 
Current treatment strategies of S. aureus born infections have become less effective as 
the pathogen has developed antibiotic resistance to broad spectrum of anti-bacterial drugs. 
 The first report of methicillin-resistant Staphylococcus aureus (MRSA) was documented 
in the early 1960´s in regard to nosocomial infections (Colley et al., 1965). Today, antibiotic 
tolerant strains are becoming increasingly prevalent and the high speed of methicillin 
resistance acquisition has become a major problem in many clinical facilities (Witte et al., 
1997). Global survey suggested that, among all S. aureus–infected patients, MRSA isolates 
are involved in 46% of cases of lung infection, 38% of urinary tract infections, 30% of 
bloodstream infections, and 30% of skin/soft tissue infections, respectively (Diekema et al., 
2001).  Although MRSA was initially described as a minor nosocomial pathogen, community 
acquired methicillin-resistant S. aureus (CA-MRSA) infections are predominant and 
widespread in modern communities (DeLeo et al., 2010).  
MRSA strain multi-drug resistance is acquired by a large transmissible element called 
staphylococcal cassette chromosome mec (SCCmec) (Sjostrom et al., 1975; International 
Working Group on the Classification of Staphylococcal Cassette Chromosome, 2009). The 
mecA gene complex determines methicillin resistance and is found on the MRSA 
chromosome. One of these genes functions by encoding a penicillin-binding protein (PBP), 
PBP2a, whose purpose is to synthesize a cell wall by linking peptidoglycan chains (de Jonge 
et al., 1992; Goffin and Ghuysen, 1998). Due to acquired PBP2a low affinity to all β-lactams, 
the protein performs cell wall biosynthesis even in the presence of antibiotics, which are not 
capable of inactivating cell wall biosynthesis (Brown and Reynolds, 1980; Hartman and 
Tomasz, 1984). 
Another strategy used by S. aureus to withstand antibiotic treatment is its ability to form 
small colony variant (SCV) subpopulations and biofilm (Chuard et al., 1997). The background 
of SCV physiological changes are mutations in genes involved in the electron transport 
chain. This results in a reduction of adenosine triphosphate (ATP) levels and a slowing down 
of bacteria metabolism. It is believed that such alterations influence bacterial intracellular 
fitness and are responsible for an increased tolerance to antibiotics (Proctor et al., 1998). 
Biofilm formation is yet another mechanism used by S. aureus to tolerate antibiotic 
therapy and promote infection (Mah and O'Toole, 2001). The ability of bacteria to attach to 
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a solid surface of biotic or abiotic origin leads to the formation of biofilm, which represent a 
microbial community covered with an exopolysaccharide matrix and related proteins. 
Antibiotic treatments often fails as drugs are not able to diffuse past the polymeric capsule 
of biofilm to reach the targeted bacteria (Stewart and Costerton, 2001).  
Considering the ever increasing number of life-threatening S. aureus infectious diseases 
and the rapid development of multi-drug resistant strains, it is clear that this pathogen is a 
priority in infectious disease research (Plata et al., 2009). 
 
1.3. S. aureus virulence factors and their role in infection process 
Each step of the infection process depends on the interplay between S. aureus virulence 
factors and the host immune system (Archer, 1998), which determines whether the 
infection remains localized or enters the bloodstream to cause a systemic response 
(Jefferson, 2009  ). For this reason, it is important to determine which particular virulence 
factors are expressed by a bacterium. This knowledge would allow for a more accurate 
prediction of pathogen behavior during the different steps of S. aureus infection including 
host colonization and the formation of a local infection/abscess or subsequent 
dissemination and/or the development of sepsis with the formation of septic 
metastases/toxinosis (Archer, 1998).  
Different groups of S. aureus virulence factors have already been classified based on their 
respective functions (Table 1). These virulence factors have been shown to contribute to the 
infection progress and include adhesins anchoring bacteria to the host cell surface, invasins 
responsible for successful tissue invasion, inhibitors of phagocytosis, exo- and endotoxins 
and other factors modulating host immune response as well as antibiotic resistance 
determinants (Zecconi and Scali, 2013).  
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Table 1. Virulence determinants of S. aureus 
Virulence factor name 
Abbreviat
ion 
Main function Proven effects  References 
Microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) 
Fibronectin-binding 
protein A and B 
FnBPA 
and 
FnBPB 
Binds to 
fibronectin and 
fibrinogen 
Staphylococcal uptake 
promotion by non-
professional phagocytes. 
Activation of endothelial cells 
Heying, 
2007 
Clumping factor A ClfA 
Binds to 
fibrinogen 
Inhibition of phagocytosis Clarke, 2006 
Clumping factor B ClfB 
Binds to  
fibrinogen 
Interaction with epithelium, 
tissue colonization properties 
O´Brien, 
2002  
Collagen-binding 
adhesin 
Cna 
Binds to  
collagen I and IV 
Role in septic arthritis 
development 
Patti, 1994 
Serin-aspartic acid-rich 
proteins 
Sdr 
proteins 
Binds to ECM Nasal colonization Sabat, 2006 
S. aureus surface 
protein 
Sas 
proteins 
Binds to ECM Nasal epithelim binding  Roche 2003 
S. aureus protein A Spa 
Binds to Fc 
chain of 
immunoglobulin
s, von 
Willebrand 
factor, TNFR1, 
mammalian 
gC1q-R 
Prevents opsonization and 
phagocytosis, modulates TNF 
signaling, role in pneumonia 
progression 
Cedergen, 
1993; 
Gomez, 
2004; 
Hartleib, 
2000; 
Nguyen, 
2000  
Secreted expanded repertoire adhesive molecules (SERAMs) 
Extracellular adherence 
protein 
Eap 
Binds to ECM, 
ICAM-1, 
interfare ICAM-
1-LFA-1 
interaction 
Impaired neutrophil and T 
cell involvement, prevents T 
cell division, inhibits MAPK 
signaling 
Chavakis, 
2002; 
Haggar, 
2004; 
Athanasopo
ulos, 2006, 
Sobke 2006, 
Lee 2002 
Coagulase Coa 
Activates 
prothrombin 
interaction with platelets 
Panizzi, 
2006; Sawai, 
1997 
ECM binding protein Emp 
Interacts with 
ECM 
Unknown 
Hussain, 
2001  
Extracellular fibrinogen 
binding protein 
Efb 
Binds to 
fibrinogen, 
binds to 
complement 
factors C3b and 
C3d 
Complement inhibition, 
inhibition of 
opsonophagocytosis, blocks 
platelets aggregation 
Lee, 2004; 
Lee 2004; 
Hammel, 
2007; 
Shannon, 
2005 
IsdA   
Binds to various 
receptor 
including ECM  
Adherence to desquamated 
epithelium 
Clarke, 2004 
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Sbi   Binds to IgG 
Binds to IgG and β2 
glycoprotein 
Zhang, 1998 
Enzymes 
Catalase CatA 
Hydrogen 
peroxide 
neutralization 
Crucial enzyme for survival, 
persistence and colonization  
Cosgrove 
2007 
Alkylhydroxide 
reductase 
AhpC Catalase activity 
Together with CatA is crucial 
enzyme for survival, 
persistence and colonization  
Cosgrove 
2007 
Proteases (V8 protease, 
aureolysin, staphopain) 
Sasp, 
Aur, ScpA 
Tissue invasion 
and other 
effects on 
pathogenesis 
Activation-inactivation and 
modification of various 
pathogen and host molecules 
Sieprawska-
Lupa, 2004; 
Shaw, 2004 
Fatty acid-modifying 
enzyme 
FAME 
Fatty acid 
modification 
Inactivation of bactericidal 
fatty acids 
Kapral, 1992 
Staphylokinase Sak 
Plasminogen 
activation 
Anti-defensin, inhibition of 
complement 
Jin 2004 
Toxins 
α-toxin Hla 
Pore formation 
activity 
Induction of inflammatory 
response  
Fournier, 
2005 
β-Hemolysin Hlb 
Lysis of 
cytokine-
producing cells 
Cytotoxicity 
Dinges, 
2000 
δ-hemolysin Hld 
Neutrophil/mon
ocyte binding 
TNF-alpha induction, 
chemoattraction 
Somerville, 
2003 
γ-hemolysin; Panton-
Valentine leukocidin; 
leukocidins D, E, M 
Hlg, PVl, 
LukD, 
LukE, 
LukM 
γ-hemolysin 
causes 
hemolysis, PVL 
activates and 
lyses 
neutrophil/mon
ocyte   
Role in necrotizing 
pneumonia due to influence 
on expression and 
representation of 
staphylococcal proteins 
Labandeira-
Rey,2007 
Superantigen toxins 
(staphylococcal 
enterotoxin, TSS) 
SE 
Food poison, 
toxic shock 
syndrome 
T cell activation, facilitation of 
MHC-II-TCR interaction 
Thomas, 
2007 
Formylpeptides fMLPs 
binds to formyl 
peptide 
receptor (FPR) 
Chemoattractants expression Le, 2002 
Anti-inflammatory ligands 
Chemotaxis inhibitory 
protein of S.aureus 
CHIPS 
Binds to C5aR 
and FPR 
Inhibition of chemotaxis 
de Haas 
2004, 
Postma 
2004, Haas, 
2004 
FPR-like 1 inhibitory 
protein 
FLIPr 
Binds to FPR-like 
1 receptor 
Inhibition of chemotaxis Prat, 2006 
Staphylococcal 
complement inhibitor 
SCIN 
Stabilizes C2a-
C4b and Bb-C3b 
enzymes 
Inhibition of complement 
Roojakkers, 
2005 
8 
 
Cell wall factors 
Teichoic acids LTA, WTA 
Binds to Toll-like 
receptor 2 
Activation of cytokines and 
chemokines expression 
Fedtke, 
2004 
 
Table 1. Selected major virulence factors of S. aureus their functions and role in pathogenicity (Chavakis et al., 
2007).  
 
S. aureus adhesins facilitate adherence of the pathogen to the host cell membrane at the 
initial stage of infection. They are usually divided into two groups: a microbial surface 
component recognizing adhesive matrix molecules (MSCRAMMs) (Foster et al., 2014) and 
secretable expanded repertoire adhesive molecules (SERAMs) (Sinha and Herrmann, 2005). 
The first group includes fibronectin binding proteins A and B (fnbpa, fnbpb) as well as clump 
factors A and B (clfa, clfb) which are anchored into the bacterial cell wall and mediate 
pathogen attachment through binding extracellular matrix proteins such as fibrinogen, 
fibronectin and collagen (Heying et al., 2007; Clarke and Foster, 2006). The second group of 
adhesins including eap and emp proteins belong to a group of secreted adhesion molecules. 
These facilitate pathogen adhesion only after the initial binding to the respective ligand of 
the host origin such as ICAM-1 or extracellular matrix proteins. Additionally, this group of 
adhesins has been shown to be involved in the inhibition of leukocyte adhesion and 
recruitment to the endothelial surface (Haggar et al., 2004).  
Another group of virulence factors is the invasins. This group consists of heterogeneous 
virulence factors that include different proteolytic enzymes such as lipases (Cadieux et al., 
2014), proteases (Kolar et al., 2013) and nucleases (Berends et al., 2010) or hyaluronidase 
with the function of invading surrounding tissues and protecting the pathogen from the 
host’s immune defense (Lowy, 1998).   
S. aureus also expresses a broad spectrum of toxins such as alpha-toxin, sigma-toxin and 
Panton-Valentine leucocidin, which influence phagocytic activity, the migration of 
leukocytes and cause affected cells to be induced to commit cell death (Chavakis et al., 
2007). It is postulated that S. aureus virulence factors such as spa, clfa, clfb and 
staphylokinase (sak) are also involved in evading the immune system by protecting bacteria 
from host immunoglobulin opsonization and compliment system (Rooijakkers et al., 2005). 
Various effects and functions of bacterial virulence factors have been studied using wild-
type and mutants forms of pathogen in  in vitro models [typically different cell cultures] and 
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in vivo models [murine models of septic arthritis] (Palmqvist et al., 2002) or systemic 
infection models (Kropec et al., 2005) etc. 
In clinical study of S. aureus, isolating virulence factor expression, revealed doubts that a 
single virulence factor predominantly defines the success and severity of infection (Peacock 
et al., 2002). Moreover, the deletion of single or multiple virulence factors could not 
guarantee a decrease in the severity of infection or eliminate the pathogen’s ability to cause 
infection (Jonsson et al., 1985; Patti et al., 1994). Such observations can be partly explained 
by the broad spectrum of S. aureus virulence determinants, which often have similar 
functions and are capable of substitution during infection (Arvidson and Tegmark, 2001). 
It is difficult to trace the function of a specific staphylococcal virulence factor during 
disease development (Fournier and Philpott, 2005; Foster et al., 2014), although 
correlations between isolates´ virulence and certain diseases have been documented 
(Nilsson et al., 1999). For example, the importance of collagen binding factor (cna) was 
demonstrated in a study using S. aureus mutants in a septic arthritis murine model. The S. 
aureus cna mutants had lower adhesion rates to cartilage and induced lower immune 
response  (Patti et al., 1994). In the murine animal model, Protein A (spa) virulence factor 
was shown to propagate arthritis development accompanied by an increased mortality rate 
when compared with the bacteria deletion spa mutants (Palmqvist et al., 2002).  
Although the pathogen has developed a wide array of virulence factors, the host also has 
a set of defense counter measures, which are discussed in the next section. 
 
1.4. The innate immune system response to S. aureus infections 
For a host organism without a functional immune system, any infectious disease has the 
potential to be life-threatening. Innate and acquired immune system responses are two 
different mechanisms of host defense (Luster, 2002). An innate immune response is the 
non-specific “quick” answer by an organism to any kind of invading pathogen or antigen 
(Tosi, 2005).  
Three important defense components of the innate immune system against S. aureus 
infection are antimicrobial peptides, compliment system and phagocytes (Rooijakkers et al., 
2005). The phagocytes include diverse populations of mast cells, dendritic cells, 
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macrophages, granulocytes, NK cells, T cells and non-professional phagocytes usually 
presenting as epithelial and endothelial cells (Basset et al., 2003). 
The cellular defense response starts with the initial recognition of antigen signals by specific 
receptors (Fig. 2) of immune competent cells of first line of defense – the skin and mucosal 
epithelium or endothelium, which respond by starting the production of chemoattractants 
to recruit immune competent cells to the site of infection (Philpott et al., 2001).  
 
 
 
 
Figure 2. Pattern recognition receptors and their role in innate and adaptive immunity (Basset et al., 2003). 
 
Recent studies suggested the important role of the endothelium in primary immune 
response to S. aureus. Thus, the role of endothelium can be viewed as initial detection of 
pathogen invasion, activation of pro-inflammatory phenotype and providing signals to 
professional phagocytes such as macrophages and/or neutrophils, which, in turn, 
responsible in ensnaring and killing the pathogen (Harding and Kubes, 2012; Rooijakkers et 
al., 2005).  
 
 
 
 
11 
 
1.4.1. Endothelium in the innate immunity 
With regard to S. aureus-induced immune response, it is necessary to underline the 
important role of the endothelium. This type of tissue is an important component of the 
host immune system and plays a crucial role in innate and acquired immunity. The 
endothelium forms the inner surface of blood and lymphatic vessels. Some calculatory 
approaches suggest a total surface area in the range of four to seven thousand square 
meters including about 10¹³ endothelial cells in the average human adult (Lemichez et al., 
2010).  
The barrier function of endothelium plays a central role in regulating vascular 
homeostasis, angiogenesis, permeability, solute exchange, vascular tone, 
coagulation/anticoagulation cascade and inflammation (Michiels, 2003). Endothelial cells 
react to environment changes by switching off their anti-thrombotic, anti-inflammatory 
phenotype to allow for a vasodilated state with the initiation of inflammation and 
coagulation events (Dandona, 2002).   
Endothelial cells have been shown to detect various pathogen associated molecular 
patterns. This ability classifies endothelium as part of the defense mechanism by which 
innate immunity detect and eradicate potential invaders (Harding and Kubes, 2012). 
Upon sensing the pathogen via pattern recognition receptors, endothelial cells transition 
into an activated state. The resulting endothelium pro-inflammatory activation involves the 
expression of surface adhesion molecules and the production of chemoattractants and 
cytokines to initiate inflammation (Szmitko et al., 2003).   
Inflammatory response of endothelium is a combination of modifications including 
vasodilation, endothelial cells pro-inflammatory response and barrier function 
dysregulation. These changes make endothelium inflammatory response one of the key 
regulators of the interactions between blood leukocytes and the site of infection, 
autoimmune process or tumor development (Valbuena and Walker, 2006).   
Inflamed endothelium attracts leukocytes by secreting cytokines and chemokines and 
interacts with immune cells via overexpressed adhesion molecules such as E-selectin, P-
selectin and ICAM-1. After adherence, leukocytes cross the endothelium barrier and 
extravasate to the locus of inflammation (Carlos and Harlan, 1994).  
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In this way, it would be correct to consider endothelium as an important immunological 
organ whose response is vital during the different stages of infection: from pro-
inflammatory activation to eradication of intracellular pathogens (Wood, 2006 ). 
 
1.4.2. Endothelium – S. aureus infection  
In most cases, S. aureus can enter the blood through damaged skin or by translocation 
through endothelium from the initial site of infection (Edwards and Massey, 2011). Once a 
pathogen has access to the bloodstream it can cause the formation of multiple abscesses in 
distant organs as well as over-activating the immune response, partially due to endothelium 
inflammation. Blood infections can result in septic shock and are known to lead to multi-
organ failure with potentially fatal outcomes (Archer, 1998).  
The interactions of S. aureus with human endothelial cells has a big impact on the 
infection process in a number of human diseases (Table 2) including endocarditis, the 
formation of metastases, sepsis development and other clinical complications (Lowy, 1998). 
Furuncle or carbuncle 
Surgical wound infection 
Botryomycosis 
Hospital-asquired bacteremia 
Acute or right-sided endocarditis 
Hematogenous osteomyelitis 
Septic arthritis 
Epidural abscess 
Brain abscess 
Hospital-asquired pneumonia 
Empyema 
Septic shock 
Toxic shock syndrome 
Scalded skin syndrome 
Food-borne gastroenteritis 
 
Table 2. Infection diseases and syndromes where S. aureus is the primary pathogen. Infections where S. aureus 
and endothelium interactions are playing a crucial role in pathogenesis are marked in bold (Archer, 1998). 
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A typical response of infected endothelium, at tissue level, includes increased 
permeability, pro-inflammatory response (Schouten et al., 2008) and, is in some cases, 
accompanied endothelium-mediated bacteria translocation through the endothelial 
monolayer (Aird, 2003).  
Loss of barrier function by endothelium is one of the hallmarks of inflammation 
development, leading to serious tissue damage and increasing the severity of infection (Aird, 
2003). 
It has been shown that abundant S. aureus alpha-toxin, due to its pore-forming activity, is 
able to lead to the loss of cell to cell contacts and dramatically increases endothelial 
permeability. The mechanism of junction disintegration during this process can be partly 
explained by actin cytoskeleton contraction due to Ca²+ influx through cellular alpha-toxin-
built-pores (Hocke et al., 2006). Additionally, it was shown that alpha-toxin interacts with its 
receptor A-disintegrin leading to increased metalloprotease activity and the disruption of 
cadherin adherent junctions (Powers et al., 2012).  Staphylococcal exotoxin B (SEB) also acts 
in intracellular gap formation and barrier failure via protein tyrosine kinase (PTK) 
phosphorylation (Campbell et al., 1997). 
 
Figure 3. Possible mechanisms of S. aureus translocation through endothelium barrier. A. Transcytosis, B. 
Paracytosis, C. Macroaperture formation mediated by EDIN toxin, D. Phagocytotic transport, E. Endothelium 
damage and thrombus formation (Modified according to (Edwards and Massey, 2011)). 
 
In order to reach the bloodstream, a bacterium has to cross the endothelial cell barrier 
(Fig. 3). S. aureus’ ability to colonize and translocate through endothelium is perfectly suited 
to facilitate bypassing this obstacle and the mechanism used also allows less well adapted 
intracellular pathogens to similarly disseminate and escape from local immune response 
(Lemichez et al., 2010) 
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It is reported that bacteria can exploit several different mechanisms to cross the 
endothelial barrier. One such tactic is transcytosis; a process by which pathogens are able to 
pass the endothelial barrier through inner cellular compartments that allow traffic in both 
directions. It is currently unknown whether S. aureus can translocate through the 
endothelial monolayer by transcytosis (Edwards and Massey, 2011).  
Paracytotic pass and cross along junction openings may occur during S. aureus infection 
as toxins produced and endothelial oxidative stress as well as cytokine release can cause 
junctional gaps to form (Scriba et al., 2008; Jonkam et al., 2009). In the case of septic 
endocarditis, S. aureus causes endothelial damage and thrombus formation which is used as 
a gateway for pathogen translocation and subsequent dissemination (Mylonakis and 
Calderwood, 2001). There is evidence that staphylococcus can cross the endothelium by 
concealing itself inside infected professional phagocytes where it can survive for significant 
periods of time (Kubica et al., 2008). Another possible mechanism used to reach the 
bloodstream involves the formation of macroapertures, large channels in the cellular 
membrane that allow bacteria to cross the endothelial barrier. Macroaperture formation 
has been reported to be mediated by S. aureus toxins named epidermal cell differentiation 
inhibitors (EDINs), which modulate the actin cytoskeleton by interacting with host cell Rho 
GTPases (Boyer et al., 2006; Edwards and Massey, 2011). 
 
 
Fugure 4. Mechanisms involved in S. aureus internalization by non-professional phagocytes including 
endothelium. (I) The major mechanism for S. aureus internalization by non-professional phagocytes is 
determined by FnBPs interaction with α5β1 integrins via Fn. (II) FnBPs also bind to human Hsp60 thereby 
contributing to S. aureus internalization. Hsp60 may function as a co-receptor for a5b1 integrins. (III) The S. 
aureus extracellular adherence protein Eap has been shown to play a role in S. aureus internalization. A host 
cell receptor for Eap is not known. (IV) Autolysin/adhesins Atl from S. aureus also promotes staphylococcal 
internalization by host cells. As the host cellular receptor, the heat shock cognate protein Hsc70 was identified 
(Hirschhausen et al., 2010). 
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Endothelial tissue shows specific reactions during S. aureus infection at the cellular level. 
The first step of host-pathogen interactions begin with bacteria adhering to the cell surface 
(Fig. 4). The mechanism of adhesion includes bacteria interacting with adhesins and their 
counterparts at the endothelial surface. Bacterial fibronectin binding proteins (FnBPs) attach 
to the cell surface by direct adhesion of FnBP to heat shock protein 60 (Hsp 60) 
(Dziewanowska et al., 2000) or through a fibronectin molecular bridge that connects FnBP 
with integrin α5β1 (Sinha et al., 1999). One more potential player is autolysin/adhesion 
factor Atl. It has been shown, on endothelial cell line Ea.hy 926, that Atl is responsible for 
adhering the heat shock cognate protein Hsc70 on the cell surface and promotes the 
internalization of pathogens (Hirschhausen et al., 2010).  Other bacterial adhesins have also 
been shown to play a role in the adhesion to endothelial cells such as can (collagen 
adhesion), clfa and clfb (fibrinogen adhesion) and eap (plasma proteins adhesion). However, 
the specific receptors on the endothelial cell surface exploited by these factors are largely 
unknown (Sinha and Herrmann, 2005). 
Following adhesion, integrins function as endocytotic receptors and promote complex 
signaling to stimulate bacteria uptake. Integrin-mediated uptake of S. aureus has been 
demonstrated to be co-localized  by a number of integrin-associated proteins: vinculin, 
paxillin, zyxin, tensin, focal adhesion kinase (FAK) and Src kinase (Hoffmann et al., 2011).  
These proteins´ interactions result in the reorganization of actin and the internalization of 
the pathogen (Agerer et al., 2005).  
The intracellular fate of S. aureus in the inner compartment of endothelial cells depends 
on bacteria virulence determinants. After phagocytosis bacteria normally stay in phagosome 
vesicles that are acidified after fusing with lysosomes. However, internalized bacteria have 
developed different strategies to avoid cellular defense mechanisms and resist low pH 
conditions (Sinha and Fraunholz, 2010). The first such strategy is to form small colony 
variants and persist inside infected cells without provoking a defense reaction (Garzoni and 
Kelley, 2009). A second strategy involves preventing phago-lysosomal fusion and/or 
disrupting the surrounding phagosomal membrane to enter into the cytoplasm. It has been 
shown that phagosomal escape of S. aureus in endothelial cells depends on several 
staphylococcal virulence factors including δ-toxin and sphingomyelinase β-toxin (Giese et 
al., 2011). There is currently no data surrounding intracellular replication of S. aureus in 
primary endothelium, although bacterium has been shown to proliferate in cytoplasmic 
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milieu of professional and non-professional phagocyte cell lines upon phagosomal escape 
(Grosz et al., 2014). In addition, S. aureus has been shown to invade and persist in the 
intracellular environment, but rapid intracellular growth was not observed in human 
osteoblasts (Ellington et al., 2001) or epithelium (Kahl et al., 2000). 
Endothelial cells are able to ‘sense’ the presence of S. aureus once bacteria ligands have 
bound to a certain set of the receptors of the innate immune system (Opitz et al., 2009). 
Bacterial cell wall components or genome degradation products have been demonstrated to 
induce endothelial expression of Toll-like receptors 2 and 4 (Faure et al., 2001), intracellular 
receptor NOD2 (Davey et al., 2006; Oh et al., 2005), RIG-I receptor and TNFR1 (Imaizumi et 
al., 2002).  
Pro-inflammatory endothelial response is a fast reaction in response to sensing a 
staphylococcus infection. Inflammation of endothelial cells can be activated by a number of 
S. aureus determinants such as alpha-toxin (Pruefer et al., 2002), fibronectin binding protein 
A (fnbpa) and components of polysaccharide capsule and cell wall including 
muramyldipeptide (MDP) and lipoteichoic acid (LA) (Heying et al., 2007). As a result of 
activation, endothelial cells release a number of chemokines and cytokines and upregulate 
adhesion molecules VCAM-1, ICAM-1 and E-selectin (Tessier et al., 1998). The cytokines 
attract and the adhesion molecules mediate the binding of leukocytes to the endothelium 
(Beekhuizen et al., 1997).  
Initial receptor activation leads to phosphorylation events in the MAPK signaling cascade, 
a complex process of interplay between kinases which  subsequently results in the 
activation of nuclear factor NF-kB and other transcription factors such as STAT1, AP-1 etc. 
(Aird, 2003). Respective upregulation of genes contributing to endothelial immune response 
upon S. aureus invasion has demonstrated an emphasized expression of molecules from all 
six cytokine families such as interleukins, cytotoxic cytokines, colony-stimulating factors, 
interferons, growth factors and chemokines (Fournier and Philpott, 2005). 
During infection, host cells can be seriously damaged and subsequently be induced into 
apoptosis. This process has been shown to involve death receptor signaling, stress stimuli 
and damage by intracellular bacterial replication (Kahl et al., 2000) or bacterial toxins 
(Dinges et al., 2000). The process of endothelium cell death plays an important role in 
amplifying the immune response and eliminating damaged/mutated cells from affected 
tissue (Thompson, 1995). 
17 
 
Currently, little is known about the mechanism of inducing cell death in endothelium 
upon S. aureus infection. It is suggested that for host cell death to occur in response to 
infection, S. aureus has to be taken up into the cell and must remain viable once inside, as 
demonstrated by using UV-inactivated bacteria and phagocytosis inhibitors (Menzies and 
Kourteva, 1998). Other studies have reported that pathogen-induced endothelial cell death 
requires invasiveness and haemolytic features by which agr and sigB regulators need to be 
functional (Haslinger-Loffler et al., 2005a). Staphylococcal pyrogenic toxin superantigens 
(PTSAgs) such as TSST-1 have also been reported to be cytotoxic for human pulmonary 
artery endothelium (Lee et al., 1991) as well as staphylococcal enterotoxin B (SEB) for 
porcine endothelial cells (Campbell et al., 1997).  
Esen and colleagues showed the importance of JNK phosphorylation, releasing 
cytochrome-C, activating caspases 3 and 8 and the role of acidic sphingomyelinase during S. 
aureus-mediated endothelium cell death (Esen et al., 2001). Furthermore, inflammasome 
NLRP3 seems to be one of the factors that contribute significantly to S. aureus-induced cell 
death in endothelium (Yin et al., 2009) and endothelium activation (Xiang et al., 2011; Xiao 
et al., 2013). However, in vice versa, S. aureus infection can lead to NLRP3 activation (Sinha 
and Fraunholz, 2010), which likely occurs through mitochondrion toxin-mediated release of 
cathepsin (Munoz-Planillo et al., 2009). 
While the endothelium quickly responds to staphylococcus infection in a variety of ways 
including helping activate an immune response to combat the pathogen, the condition of 
the host immune system prior to infection is of crucial importance. Nevertheless, bacteria 
also have variety of mechanisms allowing them to evade the immune system and induce the 
development disease regardless of the physical condition of the host. 
 
1.5. Different strains of S. aureus cause diverse responses in 
endothelium 
The infectious capacity of a particular S. aureus strain is mostly related to the genetic 
modulation of the bacterial genome, a process which can result in a type of adaptation for 
sufficient survival, colonization and growth within a host.  
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Strain-specific host responses are determined by differences in the expression profile of 
virulence factors by particular S. aureus strain. A single mutation has the potential to alter 
any stage of pathogenesis even going so far as to change the entire scenario of infection. 
One of the factors crucial for S. aureus virulence is functional agr global regulator. 
Specifically, it was shown that, during infection, isolated S. aureus strains undergo 
mutations in the agr regulatory system (Shopsin et al., 2008). This agr system is one of the 
determinants that contribute to pathogen virulence (Traber et al., 2008) and an agr 
deficiency has been shown to support intracellular bacterial persistence and escape from 
host cell inflammatory response (Matussek et al., 2005). Similar effects are shown by small-
colony variants (SCV) of S. aureus.  SCV upregulate Crp/Fnr genes involved in arginine-
deiminase pathway (AD) due to a mutation of the hemB gene. This pathway has also been 
shown to play a role in bacteria intracellular persistence. The ATP produced in the AD 
pathway protects SCV strains from acidification. Additionally, small-colony variants have 
lower virulence factor production and a subsequent weaker immune response from the host 
which results in a very effective strategy for long-term persistence in host cells (Seggewiss et 
al., 2006).  
Using a murine renal abscess model, it was demonstrated that S. aureus virulence factors 
have distinctive functions during different stages of infection. In the experiment, mice were 
infected with several S. aureus mutants. Effects of virulence factors in dissemination, 
abscess formation, abscess maturation and secondary metastase development were 
studied. It was shown that following intravasal injection, S. aureus was cleared from the 
blood within 6 hours. Since bacteria were found in peripheral tissues/organs, a trans-
endothelial/trans-epithelial transport mechanism is assumed to take place, although this 
was not directly addressed in the study.  Following 5 days post-infection, S. aureus clumping 
factor A and B (ClfA and ClfB) mutants demonstrated decreased survival with murine blood 
showing impaired bacterial loads and abscess formation. Mutants of iron uptake genes 
sdrD, isdA and B showed a decrease in bacterial loads and reduced abscess formation. 
Extracellular adhesion protein (Eap), envelope-associated protein (Emp) and staphylococcal 
protein A (spA) virulence factors were demonstrated to be involved in abscess maturation, 
bacterial dissemination after abscess rupture and de novo abscesses formation (Cheng et al., 
2009). Differences in infectious dynamics discovered in the mice model could be partly the 
consequence of the different endothelial responses to the different S. aureus mutants. 
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Even at very early points in time strain-specific S. aureus infection can have diverse 
effects on the inflammatory reactions in endothelium. These includes changing the 
paracellular endothelial barrier function and the expression of cell adhesion molecule-1s 
including ICAM-1. Furthermore, some strains are known to have the ability to translocate 
through the endothelium (Kramko et al., 2013).  
These findings were uncovered in an experiment where endothelial cells were infected 
with 22 different clinical isolates of S. aureus as well as two well-characterized lab strains 
causing diverse and strain-specific changes in para- and transcellular endothelial barriers 
(Kramko et al., 2013).  
Endothelial cells respond to S. aureus infection by upregulating pro-inflammatory 
molecules at the gene expression level. Heterogeneous endothelial expression response to 
S. aureus was demonstrated using 18 clinical isolates. In particular, pro-inflammatory 
cytokines such as IL-6, IL-8, GM-CSF, GRO-α, RANTES (Strindhall et al., 2002) and the 
adhesion molecules E-selectin and ICAM-1 (Strindhall et al., 2005) were diversely expressed 
upon strain-specific infection. Furthermore, genes involved in cell growth, apoptosis and 
cellular interactions (Matussek et al., 2005) were also differentially expressed.  In another 
study where endothelial cells (HUVEC) were infected by septic or carriage isolates, similar 
responses for both groups of isolates were observed. Interestingly, gene expression 
variations were not higher between the groups of different origin when compared to the 
variations of gene expression within the same group (Stark et al., 2009).  This result is 
further supported with the fact that there is a certain common gene pool in endothelial cells 
containing genes influenced by all S. aureus strains, likely by non-specific virulence 
determinants. Naturally, specific genes also exist and are only activated in the endothelium 
in the presence of a specific strain (Grundmeier et al., 2010). 
In conclusion, it is clear that the interaction between endothelium and S. aureus is a 
multifactorial process of a great importance in facilitating normal innate and acquired 
immune response to staphylococcal infection. The role of endothelial cells as a natural 
barrier between different inner environmental conditions further supports its function and 
importance in homeostasis and mediating infection outcomes. 
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1.6. Aim of the study 
Although it is clear that different strains of S. aureus cause different endothelial 
responses, the specific molecular mechanisms involved in these diverse reactions is not 
clearly understood. The main goal of this study is to enrich the existing knowledge 
concerning distinct endothelial responses to strain-specific S. aureus infections using an 
endothelial cell culture model and bacterial clinical isolates.   
 Our goals are: 
 To understand the background of the strain-specific inflammatory response of 
infected HUVEC 
 To study strain-specific HUVEC gene expression upon infection with S. aureus strains 
with distinctive virulence expression profiles 
 To study strain-specific HUVEC cell death induction 
 To determine the central mechanism involved in HUVEC cell death upon infection 
with S. aureus 
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2. Materials and methods 
2.1. Materials 
2.1.1. Reagents and materials  
Name of the reagent Manufacturer 
Accutase Merck (Darmstadt, Germany) 
Agar-B Difco Laboratories (Becton Dickinson, Heidelberg, 
Germany) 
Bovine serum albumine (BSA) GE healthcare (Buckinghamshire, UK) 
Calcium chloride Merck (Darmstadt, Germany) 
Endothelial growth factor (Cattle 
eyes) 
German slaughterhouses 
DMSO  Sigma (Deisenhofen, Germany) 
Ethanol (absolute) J.T.Baker (Deventer, Netherlands) 
Gentamicin sulfate salt PAA (Pasching, Austria) 
Glass coverslips, D=15 mm Gerhard Menzel GmbH (Braunschweig, Germany) 
Glass slides (76x26 mm) Gerhard Menzel GmbH (Braunschweig, Germany) 
Glass counting chamber Sigma (Deisenhofen, Germany) 
Glutaraldehyde solution 25% Sigma (Deisenhofen, Germany) 
Glycerol Calbiochem (Bad Soden, Germany) 
Glycine Applichem (Darmstadt, Germany) 
HCl (37%) Applichem (Darmstadt, Germany) 
HEPES PAA Laboratories (Cölbe, Germany) 
Lysostaphin Sigma (Deisenhofen, Germany) 
ß- Mercapthoethanol Sigma (Deisenhofen, Germany) 
Mounting medium Agilent Technologies (Santa Clara, United States) 
Paraformaldehyd (PFA) Merck (Darmstadt, Germany) 
PCR-film Eppendorf  (Homberg, Germany) 
PCR plates (96-well, colorless) Eppendorf  (Homberg, Germany) 
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PBS  Ca2+-, Mg2+- Gibico (Carlsbad, USA) 
Sodium chloride Merck (Darmstadt, Germany) 
KAPA2G Fast Readymix with Dye PeQlab (Erlangen, Germany) 
Tryptic Soy Broth (TSB) Sigma (Deisenhofen, Germany) 
Tumor necrosis factor α (TNF-α) Life Technologies (Darmstadt, Germany) 
Yeast extract Difco Laboratories (Heidelberg, Germany) 
 
2.1.2. Equipment 
Equipment Manufacturer 
Autoclave (Systec DX-65)   Systec (Linden, Germany) 
Shaking Incubator (GFL 3031)   
Heraeus instrument (Hanau, Germany) 
Safety Cabinet (safe 2020) 
Thermo Fisher Scientific  (Waltham, USA) 
Automated cell counter (TC20) BioRad Laboratories (München, Germany) 
Centrifuges (5804R, 5415R, 5415D, 
5424R, 5430R and 5810R)   
Eppendorf  (Homberg, Germany) 
CO2-incubator  (Heracell ™240i) Thermo Fisher Scientific (Waltham, USA) 
Inverted confocal microscope  
(LSM780 ELYRA PS.1) 
Carl Zeiss (Jena, Germany) 
Electronic scales 1474 (max. 1600.0g) Sartorius  (Göttingen  , Germany) 
Freezer (-80⁰C)   Sanyo (Moriguchi, Germany) 
Freezer (-20⁰C ) Sanyo (Moriguchi, Germany) 
Fridges with freezers (-20⁰C) Liebherr (Bulle, Switzerland) 
Heating/drying oven (Model 100-800) Memmert (Schwabach, Germany) 
HiScan-SQ array scanner Illumina (San Diego, California, USA) 
Ice Flaker AF103  Scotsman (Illinois, USA) 
Inverted Microscope (Axio observer 
Z1) 
Carl Zeiss (Jena, Germany) 
Inverted Microscope (Axio Vert.A1) Carl Zeiss (Jena, Germany) 
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Mastercycler™ ep realplex Real-time 
PCR System 
Eppendorf  (Homberg, Germany) 
Mastercycler™ flexlid nexus gradient  Eppendorf  (Homberg, Germany) 
Cube 6, flow cytometer Sysmex Partec (Görlitz, Germany) 
pH-meter (PB-11) Sartorius (Goettingen, Germany) 
UV/visible nanophotometer IMPLEN (München, Germany) 
Vortex mixer –MS3    IKA (Staufen, Germany) 
Micro-centrifuge, Sprout™ Kisker Biotech (Steinfurt, Germany) 
Water bath   GFL (Burgwedelf, Germany) 
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2.1.3. Solutions, buffers, medium. 
All buffers, solutions and medium were prepared using sterile filtered ddH₂O unless otherwise 
indicated. 
Standard TSB medium for bacteria cultivation (1L): 
Tryptic Soy Broth 30 g 
 
30 g of tryptic soy broth was dissolved in ddH₂O water and autoclaved. 
TSB agar plates (1L): 
Tryptic Soy Broth 30 g 
Agar 15 g 
 
30 g of tryptic soy broth and 15 g of agar-b was dissolved in water and autoclaved. After autoclaving, 
solution was distributed into plastic Petri dishes (Sarstedt, Nümbrecht, Germany) 
Binding buffer for anti-annexin V antibodies staining (10x): 
Water solution of: 
HEPES 0.1 M 
Sodium Chloride 1.4 M 
CaCl₂ 25 mM 
 
When using 10x solution was diluted to 1x and pH was adjusted (recommended pH is 7.2). 
2% Paraformaldehyde (PFA) for cells fixation: 
 
2% PFA was prepared in PBS and dissolved at 60⁰C. Add 1M of NaOH until the solution clears. The pH 
was adjusted to 7.2. Prepared solution was aliquoted and frozen at -20⁰C. 
2 mM glycine: 
Glycine was prepared in PBS in concentration 2 mM. 
1% BSA: 
1% BSA was prepared in PBS and stored at +4⁰C. 
Gentamycin solution: 
10 mg/ml gentamycin sulfate salt in ddH₂O. 
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2.1.4. Commercial reagent kits 
Name Manufacturer 
RNeasy Mini Kit (50) Qiagen (Venlo, The Netherlands) 
Illumina TotalPrep RNA Amplification Kit  Life Technologies (Darmstadt, Germany) 
HumanHT-12 v4 Expression BeadChip Kit Illumina (San Diego, California, USA) 
HumanHT-12 v4 Expression BeadChip Illumina (San Diego, California, USA) 
Reverse Transcription Core Kit Eurogentec (Liege, Belgium) 
Nuc-View 488 Caspase-3 assay kit for live cells Biotium (Hayward, CA, USA) 
 
2.1.5. Antibodies/reagents 
Name of antibody/reagent Conjugate Manufacturer Application* 
Mouse anti-human CD54 (clone 
1H4) 
FITC Immunotools (Friesoythe, Germany) FC 
Mouse IgG2b isotype control FITC Immunotools (Friesoythe, Germany) FC 
Recombinant chicken Annexin 
V 
FITC Immunotools (Friesoythe, Germany) FC 
Propidium Iodide - Sigma (Deisenhofen, Germany) FC 
Phalloidin TRITC Sigma (Deisenhofen, Germany) IF 
NQDI-1 - Axon Medchem (Groningen, The 
Netherlands) 
IA 
SB203580 - Life Technologies (Darmstadt, 
Germany) 
IA 
PD98059 - Life Technologies (Darmstadt, 
Germany) 
IA 
Wortmannin - Merck (Darmstadt, Germany) IA 
Bisindolylmaleimide I - SantaCruz (Dallas, Texas, USA) IA 
SP600125 - SantaCruz (Dallas, Texas, USA) IA 
*FC – flow cytometry, IF – immunofluorescence, IA – inhibition assay 
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2.1.6. Bacteria strains  
Strain Characteristic Reference 
S. carnosus 
TM300 
Non-pathogenic Staphylococcus (Schleifer and Fischer, 1982) 
S. aureus K9976 Sepsis isolate (blood), MSSA, hemolysis 4 (Kramko et al., 2013) 
S. aureus K3010 Sepsis isolate (blood), MRSA, hemolysis 3 (Kramko et al., 2013) 
S. aureus 6850 Derivative from sepsis with metastatic bone 
infection, MSSA, hemolysis 3 
(Balwit et al., 1994) 
S. aureus 
K9657/04 
Sepsis isolate (blood), MSSA, hemolysis 0-1 (Grundmeier et al., 2010) 
S. aureus 
K70058396 
Sepsis isolate (blood), MRSA, hemolysis 3-4 (Kramko et al., 2013) 
S. aureus 8325-4 Derivative of conjunctivitis isolate NCTC 8325, 
MSSA, hemolysis 2 
(Kramko et al., 2013) 
S. aureus K10485 Sepsis isolate (blood), MRSA, hemolysis 0-1 (Kramko et al., 2013) 
S. aureus K528 Sepsis isolate (blood), MSSA, hemolysis 3 (Kramko et al., 2013) 
S. aureus 
K1801/10 
Sepsis isolate (blood), MRSA, hemolysis 2 (Kramko et al., 2013) 
S. aureus 
K2900/10 
Sepsis isolate (blood), MRSA, hemolysis 0-1 (Kramko et al., 2013) 
 
2.1.7. Cell culture reagents 
Chemicals and materials used during cell culture manipulation. 
Name Manufacturer 
M199 medium Sigma (Deisenhofen, Germany) 
0.2% collagenase A solution Roche  (Mannheim, Germany) 
0.05% trypsin-ethylene diamine tetraacetic acid (EDTA) Merck Millipore, Billerica, USA 
0.5% gelatine Sigma (Deisenhofen, Germany) 
Complete Promocell medium for endothelium Promocell (Heidelberg, Germany) 
Penicillin/Streptomycin (P/S) PAA Laboratories (Cölbe, Germany) 
Fetal calf serum (FCS) Pan Biotech (Seoul, South Korea) 
6-well and 12-well plates (for cell culture) Greiner bio-one (Frickenhausen, Germany) 
Cell culture flask, 25 cm² Greiner bio-one (Frickenhausen, Germany) 
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2.2. Methods 
2.2.1. Isolation and maintenance of human umbilical vein endothelial cell 
culture (HUVEC) 
Human umbilical cords were obtained from Münster University Hospital (UKM). The Jaffe 
isolation method was used in accordance with the permission of the ethics commission 
(2009-537-f-S) (Jaffe et al., 1973).  
The umbilical cords pieces of 20-30 cm were briefly prepared with a sterile scalpel. Both 
ends were closed with clamps and the cord was soaked for 30-60 seconds in 70% ethanol. 
Afterwards, the umbilical vein was cannulated with a blunt needle and injected by the pre-
warmed PBS until the efflux was transparent. After cleaning, the vein was perfused with 
0.2% collagenase A solution, closed and incubated in warm PBS for 10 minutes in a suitable 
volume. Following this, the cord was agitated gently to enable the cell detachment. The 
collagenase solution containing endothelial cells was collected into a falcon tube with pre-
warmed M199 medium containing 10% FCS, 1% P/S, 1% sodium pyruvate and L-Glutamine. 
After centrifuging at 1200 rpm for 5 min, supernatant was discarded and the cell pellet was 
re-suspended in complete M199. The ECs were cultured in a cell culture flask coated with 
0.5% gelatin T25 and incubated at 95% air humidity, 5% CO2, and 37°C. Prior to the M199 
medium being changed the next day, the cells were washed twice with pre-warmed PBS to 
clear the culture from red blood cells and debris. The medium was exchanged every two 
days.  
Upon cell splitting, the culture medium was discarded and the cells were washed once 
with pre-warmed PBS. For approximately 2-3 minutes, 1 ml 0.05% trypsin-ethylene diamine 
tetraacetic acid (EDTA) was added to detach the cells at room temperature (RT). After the 
trypsin was removed, the flask was shaken to enable a complete detachment of the cells.  
The endothelial cells were collected by adding 1 ml of complete Promocell medium with 2% 
FCS and 1% P/S. Seeding procedure was dependent on required volume, cell density and 
desired coating.    
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2.2.2. Coating cell culture plates with or without glass coverslips 
The HUVEC were seeded in 6 or 12-well cell culture plates with coated plastic bottoms 
with or without glass coverslips. For the immunostaining of endothelial cells, 12-well cell 
culture plates with glass coverslips were used. 
To begin, the sterile glass coverslips were briefly put into each well of the 12-well culture 
plate. The glass coverslips were then coated with cross-linked gelatin using the following 
procedure: washing once with PBS, adding pre-warmed 0.5% gelatin upon 30 min 
incubation at 37°C. After removing the gelatin, 2% glutaraldehyde water solution was 
applied for 15 min at RT. The glutaraldehyde was then discarded before adding 70% 
ethanol. Treatment with 70% ethanol lasted up to 1 hour to fully neutralize remaining 
glutaraldehyde. After this application, the wells were washed with PBS for 5 intervals of 5 
minutes. The wells were then incubated overnight with PBS containing 2 mM glycine at RT. 
Prior to use, plates were washed again with PBS for 5 intervals of 5 minutes.  
The plastic plates without glass coverslips were coated with 0.5% pre-warmed gelatin 
solution for 30 minutes and incubated at 37°C.   
 
2.2.3. Preparation of bacteria inoculum 
The culture of Staphylococcus aureus was seeded on TSB agar plate. After overnight 
incubation at 37⁰C, a single colony of each respective strain was picked and re-suspended in 
10 ml of TSB medium for 16 hours in a shaking incubator at 37°C (until stationary phase).  
Following incubation, the bacteria suspension was transferred into 15 ml falcon tube and 
centrifuged for 5 min at 5000 rpm (RT). The medium was discarded and bacteria were re-
suspended in 3 ml of PBS. The optical density of bacteria suspension was estimated by 
OD₆₀₀ measurement using IMPLEN nanophotometer. Afterwards, the bacteria suspension 
was added to TSB/20% glycerol medium to OD₆₀₀=1. The number of the bacteria was 
calculated using glass counting chamber using the following formula: 
Bacteria number/1 ml= cells/square x dilution factor x 1.25 x 10⁶ 
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The aliquots were frozen and stored at -20°C prior to usage. Before infection, aliquots 
were defrosted at RT and centrifuged for 5 minutes at 5000 rpm. The medium was 
discarded and the cell pellet was re-suspended in 1 ml of complete Promocell medium 
without antibiotics.  
 
2.2.4. Maintaining a HUVEC culture 
Before seeding, the amount of HUVEC in the sample was calculated using an automated 
cell counter. HUVEC were seeded on 15 mm glass coverslips or plastic culture plates with a 
cell density of 30.000 cells/cm². The cells were incubated in complete Promocell medium 
containing antibiotics until confluence.  
Prior to infection, cells were washed once with pre-warmed PBS and the medium was 
exchanged with complete Promocell medium lacking antibiotics.  
 
2.2.5. Infection of HUVEC with Staphylococcus aureus  
The HUVEC were infected with respective S. aureus strain in MOI = 50 and incubated for 
one, two or three hours depending on the experimental design (see results section). 
Following initial infection, cell cultures were treated with 20 µg/ml of the lysostaphin (LS) 
for 30 min. Subsequently, the cells were rinsed a single time with pre-warmed PBS.  
After LS application, infected cells were incubated in complete Promocell medium with or 
without antibiotics respective to the experimental design (see results section). HUVEC were 
incubated until the respective post-infection (p.i.) time point had passed. 
 
2.2.6. Immunostaining and fluorescence microscopy during caspase-3 assay 
30 minutes before the experiment was terminated, 5 µM of caspase-3 substrate was 
added to living cells by being dissolved in complete Promocell medium containing 15 µg/ml 
of gentamycin for 30 minutes at RT. At 7 hours p.i., the cells were fixed with 2% PFA for ten 
minutes at RT.  
After washing the cells twice with PBS, cells were labeled with diluted (1:500) palloidin-
TRITC (1 mg/ml, Deisenhofen, Germany) in PBS for 30 minutes,  before being subsequently 
washed three times in PBS and mounted in Dako fluorescent mounting medium.  
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Afterwards, coverslips with stained cells were mounted onto microscopy glass slides. 
Fluorescent microscopy was performed using 40x oil objective with 488 and 561 nm laser 
channels. 
 
2.2.7. Annexin V/PI apoptotic assay 
After initial infection, cells were detached using 0,5 mM of pre-warmed accutase. In turn, 
the cells were re-suspended in annexin V binding buffer (AVBB) and centrifuged for 5 min at 
1600 rpm at RT. The supernatant was discarded and the cell pellet was re-suspended in 100 
µl of the new AVBB.  
Each aliquot was divided into four respective samples and each of the following was 
transferred: 5 µl of the Annexin V, 10 µl of the PI, 5 µl of the Annexin V and 10 µl of the PI or 
nothing. After 15 minutes of incubation at RT in darkness, samples were washed with PBS/1 
% BSA one time. After centrifugation, the supernatant was discarded and the cell pellet was 
re-suspended in AVBB and analyzed by flow cytometry.   
 
2.2.8. Staphylococcus aureus intracellular survival 
The infected cells were detached using 0,5 mM of pre-warmed accutase. Each sample 
was divided in two aliquots. The first aliquot was used for counting the number of HUVEC 
using an automated cell counter. The second was used to estimate the number of 
intracellular bacteria for three post-infection points in time.  
At the respective time point based on experimental design, the HUVEC aliquot was lysed 
by application of 1% Triton X-100. After a series of dilutions in PBS, the 100 µl of bacteria 
suspension was seeded on TSB agar plates. This was followed by overnight incubation and 
counting the colonies the next day.   
 
2.2.9. Infected HUVEC phase contrast microscopy  
The time lapse recording of infected HUVEC by phase contrast microscopy was 
performed for a 24 hour period post-infection. In the experiment, 6 or 12 independent 
movies were simultaneously acquired. Each frame corresponds to five minutes of infection. 
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2.2.10. Protein kinases inhibition assay 
The pharmacological inhibitors of ASK1, p38, PKC, PI3K, ERK 1/2 and JNK were applied. All 
of the inhibitors were dissolved in DMSO, aliquoted and stored at -20°C. HUVEC were 
treated with mitogen-activated protein kinase inhibitors prior and during infection (see 
results section). To observe the effect of a respective kinase inhibitor, time lapse recordings 
of infected HUVEC by phase contrast microscopy were performed for a 24 hour period post-
infection. 
 
2.2.11. Gene expression study 
2.2.11.1. The mRNA isolation and reverse transcription 
Total mRNA was isolated from HUVEC lysate using a RNeasy mini kit in accordance with 
the protocol laid out by the manufacturer. The quality and concentration of the mRNA was 
measured using the IMPLEN nanophotometer. Prepared mRNA was frozen at -80⁰C or 
processed by reverse transcription. Subsequently, the mRNA was used to synthesize the 
cDNA using the Reverse Transcriptase Core Kit and following the following scheme: 
Reagent Volume 
500 ng of mRNA+ddH₂O 4.05 µl 
10x RT Buffer 1 µl 
25 mM MgCl₂ 2 µl 
2.5 mM dNTP 2 µl 
Oligo dT 0.5 µl 
RNase Inhibitor 0.2 µl 
Euroscript RTase 0.25 µl 
The thermocycler was programmed with the following parameters: 
Step Temperature Duration 
Primer annealing 25⁰C 10 min 
Extension 48⁰C 30 min 
Denaturation 95⁰C 5 min 
Cooling 4⁰C as needed 
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The samples were twice diluted with ddH₂O and frozen at -20⁰C or immediately used for 
RT-qPCR.  
2.2.11.2. Real-time qPCR  
During all procedures, the samples were cooled to 4⁰C. cDNA samples were mixed with 
oligonucleotides and SYBR Green qPCR Master Mix in the following order: 
Reagent Volume 
cDNA 0.8 µl 
2x SYBR Green Master mix 9.0 µl 
Primer forward 1.7 µl 
Primer reverse 1.7 µl 
ddH₂O 6.8 µl 
 
 The real-time qPCR was processed using the Eppendorf realplex thermocycler with the 
respective program: 
Step Temperature Duration 
1 cycle: 
Denaturation 95⁰C 5:00 
40 cycles: 
Denaturation 95⁰C 10 sec 
Annealing/elongation 55⁰C 15 sec 
Annealing/elongation 60⁰C 15 sec 
1 cycle (Melting curve): 
Denaturation 95⁰C 15 sec 
Annealing 60⁰C 15 sec 
Gradient temperature increase 20 min 
Denaturation complete 95⁰C 15 sec 
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The two-step qPCR with melting curve was performed for all gene expression 
experiments. Specific human primers were designed by using Universal Roche Probe Library 
(Roche, 1996-2015) (Table 4). The oligonucleotides were ordered and synthesized by 
Eurogentec.   
Genes name   Primers 5´→3´ 
Reference genes 
E-selectin Forward GAGTGCACATCTCAGGGACA 
  Reverse ACTGCCAGGCTTGAACATTT 
ICAM-1 Forward CCTTCCTCACCGTGTACTGG 
  Reverse AGCGTAGGGTAAGGTTCTTGC 
VCAM-1 Forward TGCACAGTGACTTGTGGACAT 
  Reverse CCACTCATCTCGATTTCTGGA 
GAPDH Forward GAGGGTCTCTCTCTTCCTCTTGT 
  Reverse CTCCTCTGACTTCAACAGCGACA 
Genes for microarray verification 
CLDN11 Forward CCCGGTGTGGCTAAGTACAG 
  Reverse CAACAAGGGCGCAGAGAG 
CLDN23 Forward GGACCAGTGGGGCTACTTC 
  Reverse AGCGAGGTGACCATGAGTG 
CEACAM1 Forward CCCATCATGCTGAACGTAAA 
  Reverse AGGGCCACTACTCCAATCAC 
ACTA2 Forward CCTATCCCCGGGACTAAGAC 
  Reverse AGGCAGTGCTGTCCTCTTCT 
ARHGAP1 Forward TTGTGTTTAGTGCCTGTCGAA 
  Reverse TACTGGTCCAGGGTGTGCTT 
FAM107A Forward CTGCAGTGCCCCTTTGAG 
  Reverse TCCTTCTCTGGTGGTTTTTCC 
DCP1A Forward AGCCAAGGATGAGTATGAGAGG 
  Reverse AGCTGAGTGCTTGGCTGTAAC 
FLNC Forward GCCTCCCTCTCGGATGAC 
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  Reverse GGCTGGTTCACCTTGAGC 
CCL5 Forward TGCCCACATCAAGGAGTATTT 
  Reverse CTTTCGGGTGACAAAGACG 
CCL20 Forward GCTGCTTTGATGTCAGTGCT 
  Reverse GCAGTCAAAGTTGCTTGCTG 
CXCL10 Forward GAAAGCAGTTAGCAAGGAAAGGT 
  Reverse GACATATACTCCATGTAGGGAAGTGA 
CXCL11 Forward AGTGTGAAGGGCATGGCTA 
  Reverse TCTTTTGAACATGGGGAAGC 
ATF3 Forward CGTGAGTCCTCGGTGCTC 
  Reverse GCCTGGGTGTTGAAGCAT 
EGR1 Forward AGCCCTACGAGCACCTGAC 
  Reverse GGTTTGGCTGGGGTAACTG 
EGR2 Forward TTGACCAGATGAACGGAGTG 
  Reverse TGGTTTCTAGGTGCAGAGACG 
CD47 Forward TGCTGCTCCAGACACCTG 
  Reverse CTACCAGGGGCCACATCTC 
CD68 Forward GTCCACCTCGACCTGCTCT 
  Reverse CACTGGGGCAGGAGAAACT 
CD83 Forward CGGTCTCCTGGGTCAAGTTA 
  Reverse TGTCCCCTGAGGTGGTCTT 
GBP1 Forward CCAGTGCTCGTGAACTAAGGA 
  Reverse TGTCATGTGGATCTCTGATGC 
GBP2 Forward CCCTAGTTCTGCTCGACACTG 
  Reverse AGGCAAAGATCCAGGAGTCA 
STX11 Forward AGATGTTCCACCAAAAACACG 
  Reverse AAGAACACCTGCCAAGCTGA 
RND1 Forward GCGAAGGATTGCTATCCAGA 
  Reverse GGTATCCCAGAGACTAAGCTCCA 
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RND3 Forward GCGCTGCTCCATGTCTTC 
  Reverse GCCGTGTAATTCTCAAACACTG 
TAP1 Forward TCTCGCTGTTCCTGGTCCT 
  Reverse TCTTGTAGAATCCAGTCAGTGAGG 
BCL3 Forward GCCTCAGCTCCAATGGTC 
  Reverse GAGGAGCCATGGGGAATC 
BIRC3 Forward GATGAAAATGCAGAGTCATCAATTA 
  Reverse CATGATTGCATCTTCTGAATGG 
CASP1 Forward CCTTAATATGCAAGACTCTCAAGGA 
  Reverse TAGCTGGGTTGTCCTGCACT 
CASP7 Forward CCGAGACTTTTAGTTTCGCTTT 
  Reverse CCTGATCATCTGCCATCGT 
CFLAR Forward TCCTGAACAGTACTATTTCGTGTGA 
  Reverse AGCATGAGATATAAAATGAAAAGAAGG 
TNFRSF12A Forward GACCGCACAGCGACTTCT 
  Reverse CACGAAGGTCAGGCTCAGA 
CXCR4 Forward GGATATAATGAAGTCACTATGGGAAAA 
  Reverse GGGCACAAGAGAATTAATGTAGAAT 
Table 4. The oligonucleotides were used in the study. 
 
2.2.11.3. Quantification of RT-qPCR results 
The results of RT-qPCR were obtained as Ct (cycle threshold) values. The fold expression 
change was calculated by 2−𝛥𝛥𝐶𝑡 method of relative gene expression (Schmittgen and Livak, 
2008).  
Where, fold change = 2−𝛥𝛥𝐶𝑡  
, and –ΔΔCt = [(Ct gene of interest – Ct internal control) sample 1 – (Ct gene of interest – 
Ct internal control) calibrator)]. Ct of the internal control refers to the Ct value of 
housekeeping gene GAPDH. 
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2.2.12. Microarray performance  
Total mRNA was isolated using the RNeasy Mini kit in accordance with the supplier’s 
instructions. cDNA was synthesized using the Reverse Transcriptase Core Kit (Eurogentec). 
Biotinylated and amplified RNA for direct hybridization was transcribed using the Illumina 
TotalPrep RNA Amplification Kit (Life Technologies) in accordance with the manufacturer´s 
instructions (Fig. 5).  
 
Figure 5. The schematic procedure of microarray preparation. 
For microarray, Illumina BeadChip Technology (Human HT-12 v4 Expression BeadChip) 
was used and processed using an Illumina HiScan-SQ array scanner. Quality controls and 
differential expression analyses were performed according to the Illumina Custom Model 
installed in the Genome Studio software (Illumina).  
 
2.2.13. Statistics 
The microarray data for the group comparisons was summarized as mean ± SD and 
expression differences between strains were analyzed by use of a student’s t-test and 
ANOVA followed by post-hoc Bonferroni adjustments. For the other tests, statistical 
analyses between two groups were performed by double-sided Student's t-test. The data 
was presented as mean ± SD. P-values equal or less than 0.05 were considered as significant.  
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3. Results 
3.1. Staphylococcus aureus strains that actively translocate prevent 
TNF-α-induced ICAM-1 upregulation in human endothelial cells  
A recent study (Kramko et al., 2013) demonstrated a diverse endothelial response upon 
infection with different strains of S. aureus (Kramko et al., 2013). This includes the capacity 
of the particular strain to upregulate ICAM-1 expression (Fig. 6).   
 
Figure 6.  ICAM-1 surface expression was determined in HUVEC after infection with S. aureus strains (MOI of 
50) as indicated by calculation of MF/MF0 (mean fluorescence ratio) values obtained from flow cytometry. 
Data shown is the mean from n independent experiments, as indicated, ± SEM. The p-values were determined 
related to mock-treated control (bold star). *=p≤0.05, **=p≤0.005, ***=p≤0.0005, ns=not significant (Kramko 
et al., 2013). 
Nine S. aureus strains did not demonstrate significant upregulation of ICAM-1 (Fig. 6) 
while 14 others did. Two strains (6850 or K70058396) out of 24 did not upregulate ICAM-1 
expression (Kramko et al., 2013) but in contrast did transmigrate through the endothelium 
monolayer. Next, we tested whether strains that do not induce ICAM-1 expression have the 
ability to influence immune response suppression in endothelium. To evaluate this, 
endothelial cells were infected and subsequently challenged by TNF-α, a cytokine that is 
known to upregulate ICAM-1, and increases permeability (Goldblum et al., 1993; Yang et al., 
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2005). TNF-α alone was used as a positive control while a mock treatment served as the 
negative control. The data shows that 6850, K70058396, K3010 and K9976 strains inhibited 
the TNF-α-induced upregulation of ICAM-1 and translocated trough the cell layer while all 
other tested strains showed no inhibitory effect (Fig. 7).  
 
Figure 7. Efficiently translocating S. aureus strains diminish the TNF-α-induced ICAM-1 expression in 
endothelial cells. HUVEC were infected with S. aureus with a MOI of 50 followed by a depletion of not 
internalized bacteria. Strains were subsequently treated with 100 ng/ml of recombinant TNFα for 6 hours and 
then ICAM-1 surface expression was determined by calculation of MF/MF0 values obtained from flow 
cytometry. Data shown represents the mean from n independent experiments, as indicated, ± SEM. The p-
values were determined respectively to the TNF-α treated control (bold star). **=p≤0.005, ***=p≤0.0005, 
ns=not significant, NA=not applicable (Kramko et al., 2013). 
The data demonstrates that the activation of endothelium can be blocked by particular 
strains of S. aureus (Kramko et al., 2013).  
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3.2. S. aureus display strain-related pathophysiological features in 
EC 
To further study strain-specific endothelial response, the following strains displaying 
select characteristics were chosen (Fig. 10). The selection was based on diverse 
pathophysiological effects of S. aureus previously studied (Kramko et al., 2013). ICAM-1 
expression was analyzed by flow cytometry, barrier function was examined by a 
determination of the transendothelial electrical resistance (TER) from impedance 
spectroscopic measurements and bacterial transmigration was evaluated by use of a 
transwell filter assay (Kramko et al., 2013) (Fig. 8).  
 Distinctive S. aureus strains were deliberately used in all following experimentations to 
study a maximal broad range of endothelial response upon infection.  
 
 
Figure 8. Effects of selected S. aureus strains on early endothelial response compared to controls. 
Strains were assigned as pro-inflammatory when they upregulated pro-inflammatory cell 
adhesion molecules (e.g. ICAM-1), decreased paraendothelial barrier function and did not 
transmigrate. Strains were assigned anti-inflammatory when they did not provoke 
upregulation of cell adhesion molecules, did not decrease the TER, decreased the pro-
inflammatory response in endothelium after TNF-α challenge and were able to 
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transmigrate. One strain that features mostly anti-inflammatory properties, however, 
moderately down-regulated the TER. To classify it, we termed this strain incomplete anti-
inflammatory. Strains K9657/04 and K2900/10 that affected only one of the parameters we 
labelled as areactive.  
 
3.2.1. Expression of virulence factors is strain-related   
To better characterize the selected S. aureus strains, virulence factor expressions were 
determined (Silke Niemann, Institute of Medical Microbiology). This data represents 
virulence factor expression levels of planktonic bacteria in reach medium after three hours 
of incubation for fnbpA and six hours of incubation for all other virulence factors. 
The strain-specific expression of global virulence regulators including toxins and adhesins 
was determine for each selected S. aureus strain (Table 3). Strains with a lesser pro-
inflammatory effect in the endothelium demonstrated a comparatively higher expression of 
psm (phenol-soluble modulin), sae, agr and toxins hla (α-toxin) while sarA had low levels of 
expression in all strains being investigated. Strains that influenced a profound pro-
inflammatory response expressed much less of the global regulator and toxin, particularly 
psm and sae.   
 
 
 
 
 
 
Table 3. Virulence factors expression of selected S. aureus isolates. In red is labeled the strain´ highest gene 
expression among the isolates. Data is the mean from 3 independent experiments (The experiment was done 
by Silke Niemann, institute of Medical Microbiology). 
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The expression levels of global regulators in the strains K70058396 and 6850 were very 
high. Interestingly, these strains belong to the anti-inflammatory and incomplete anti-
inflammatory strain categories, easily transmigrating through the endothelium. In contrast, 
however, the strains 8325-4 and K1801/10 showed comparatively weak expressions of 
global regulators and toxins (Table 5) and belong to pro-inflammatory or incomplete pro-
inflammatory strains. Strain K9657 and strain K2900/10 displayed mixed behaviors and 
displayed a low expression of global regulators (Table 3).  
 
3.3. Morphodynamics of cytotoxic effect of S. aureus strains in 
infected endothelial cell cultures 
To further characterize the strain-specificity of S. aureus-endothelial interactions we 
investigated cytotoxic effect of strain-specific infection. In particular, we looked for 
apoptosis and necrosis, but we also tested the capability for invasion, intracellular bacterial 
persistence and growth. 
In order to investigate the particular behaviors of S. aureus in endothelial cells, samples 
were infected and subsequent time lapse recordings of confluent endothelial cell cultures 
were performed for 24 hours (illustrated in the scheme (Fig. 9). TNF-α is a pro-inflammatory 
drug but also exhibits pro-apoptotic activity and served as positive control. 
 
Figure 9. General scheme of live cell time lapse recording experiment. 
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Figure 10. Live cell time lapse recording of S. aureus infected endothelium (20x). Images were taken after 4, 6, 
8 and 10 hour post-infection from an image sequence of 24 hours infection.  
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Figure 10 (Continued). Live cell time lapse recording of S. aureus infected endothelium (20x). Images represent 
4, 6, 8 and 10 hour post-infection. The images were exported from respective 24 hours live cell imaging movies 
for each treatment.  
 
Infection of the endothelial cells with strains 8325-4, K2900/10 and K9657/04 did not 
visually compromise endothelial monolayer integrity and induced only minor endothelial 
cell death, a behavior which corresponds to rounded-up cells being pushed out from the cell 
layer, within 10 hours following infection (Fig. 10) and were designated as non-cytotoxic. In 
contrast, infection with the S. aureus strains K1801/10, 6850 and K70058396 caused 
massive endothelial cell damage, likely by apoptosis or necrosis, with cell gap junction 
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formation starting at 4 hours post-infection (Fig. 10). Treatment with TNF-α led to 
endothelial cells elongating and inducing visible apoptotic changes after 6 hours of 
incubation (Fig. 10). 
The damaged endothelial cells showed similar apoptotic morphologies when compared 
with TNF-α-induced cell death (Fig. 11, A). Cells lost cell-to-cell adhesion, were rounded-up, 
and displayed characteristic blebbing (Fig. 11, A). The process of endothelial cell death for 
some infected cells includes the formation of a large membrane bubble and a shrinking of 
the nuclei (Fig. 11, B). 
 
 
Figure 11. Cytotoxic S. aureus strain 6850 induces profound endothelial cell death. TNF-α-induced 
endothelium cell death is presented for comparison. Red arrows indicate endothelial cell death with 
membrane blebbing. Yellow arrows demonstrate endothelial cell death with big membrane bubbles (white 
arrows) and shrunken nuclei. 
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3.3.1. Strain-specific S. aureus release from infected endothelial cells by 
“outbursts”  
During morphodynamic study, we discovered a ‘burst-like’ repeated release of bacteria from 
endothelial cells infected by the K70058396 strain. Particularly at the beginning, cells 
appeared to be rounded, possibly due to cell swelling, followed by a sudden rupturing 
process taking approximately 15 minutes and causing a massive release of intracellular 
bacteria into the medium (Fig. 12, 13). The entire process was termed “outburst”. Bacteria 
“outbursts” were observed to start between 7-10 hours after infection with the K70058396 
strain. Based on evidence from the time lapse movies it appears that these “outbursts” are 
repeated  several times by the very same cell (Fig. 13).  
Among all isolates we used during this experiment, “outburst” activity was observed only 
with strain K70058396. 
 
Figure 12. HUVEC infected with S. aureus strain K70058396. Red arrows indicate bacteria “outbursts” from 
endothelial cells.  
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Figure 13. (A) HUVEC infected with S. aureus strain K70058396. Red circles indicate repeated bacteria 
“outbursts” from the same endothelial cell.  (B) HUVEC infected with S. aureus strain K70058396 – 10 hours 
post-infection (enlarged). Red arrows indicate bacteria “outbursts” from several endothelial cells. In red circles 
are indicated released bacteria. Green box corresponds to area illustrated above (Fig. 13; A). 
The data indicates that intracellular survival and bacterial growth may occur in several 
separated intracellular compartments. Since S. aureus strain K70058396 was the only one 
that displayed this behavior, we theorize that such strains benefit from specialized 
mechanisms that enable bacterial survival and in human endothelium.  
 
3.4. Cytotoxic staphylococcus aureus strains are able to survive and 
grow in endothelium 
As demonstrated above, the apoptotic S. aureus strains K70058396 showed the capacity 
to cause “outbursts” from infected endothelial cells. We hypothesize that S. aureus 
intracellular survival and multiplication can be a characteristic sign identifying cytotoxic 
strains. To confirm intracellular survival and quantify growth rate of chosen S. aureus 
isolates, an intracellular survival assay was designed. Specifically, HUVEC cultures were 
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grown to confluency and infected with three cytotoxic S. aureus strains K1801/10, 6850 and 
K70058396 for one hour with MOI=50. As a negative control we infected endothelium with 
non-cytotoxic strain 8325-4. Cells were infected for 1 hour closely followed by a depletion of 
extracellular bacteria using lysostaphin for 30 minutes. Subsequently, infected cells were 
divided and further cultured with and without antibiotics until the experiment was 
terminated after 2,5; 4,5 and 7,5 hours post-infection (Fig. 14). HUVEC were then washed , 
lysed and a plaque assay was performed.   
  
 
Figure 14. The scheme of bacteria intracellular survival experiment 
S. aureus isolates showed different traits to survive and multiply intracellularly. The three 
cytotoxic strains showed significant intracellular growth by which strain K70058396 
demonstrated a growth rate three times higher than 6850 and six times higher than strain 
K1801/10 (Fig. 15; A). In contrast, the non-cytotoxic strain 8325-4 did not show significant 
intracellular growth, but rather continued to reside inside the cells. 
 
 Figure 15. Intracellular S. aureus survival in HUVEC (A) without antibiotics or (B) with 15 µg/ml Gentamicin. 
The data shows the number of colony forming units (CFU) per one endothelial cell. The colored columns 
indicate different points in time.  The data shown is the mean from at least three independent experiments, 
indicated as ± SEM. The p-values related to 2.5 hours incubation time point. *=p≤0.05, **=p≤0.01, 
***=p≤0.005, ns= not significant. The number of colonies was normalized to the number of endothelial cells in 
the sample, and recalculated as number of colony forming unit (CFU) per one endothelial cell. 
48 
 
To exclude the secondary internalization by extracellular bacteria released by destroyed 
endothelial cells, the same experiment was performed in the presence of 15 µg/ml 
gentamicin. Gentamicin is an antibiotic that is hardly taken up in the cells and requires over 
10 hours until a concentration equilibrium can be reached (Seral et al., 2003; Easmon, 
1979). Thus, Gentamycin has weak activity against intracellular S. aureus (Mohamed et al., 
2014).  
The presence of Gentamicin did not change the results (Fig. 15; B), which further 
demonstrates the efficient intracellular survival and intracellular growth tactics of cytotoxic 
S. aureus strains. Intracellular growth and survival seems to be a characteristic for cytotoxic 
strains and is most likely related to S. aureus-induced endothelial cell death in a strain-
specific manner.   
 
3.5. S. aureus-induced endothelial cell death 
3.5.1. Cytotoxic strains of S. aureus induce early apoptosis in endothelial 
cells.  
In the next series of experiments our goal was to better understand cell death induced by 
S. aureus. To differentiate between S. aureus early/late apoptosis and/or necrosis in HUVEC, 
a Annexin V/propidium iodide (PI) assay was performed. The Annexin V binds 
phosphatidylserine on the cell surface which is then used as the marker for early apoptosis 
while PI and double stained positive cells indicate necrosis or late apoptosis. After infection, 
extracellular bacteria were depleted by treatment with lysostaphin for 30 minutes, washing 
and further incubation until 18 hours past the initial time of infection. Subsequently, the 
percentage of Annexin V positive, PI positive or double-positive cells was determined by 
flow cytometry. 1 mM hydrogen peroxide was applied to cell cultures for one hour. The 
experimental time scale is illustrated in figure 16 (Fig. 16).  
 
Figure 16. The scheme of Annexin V/PI apoptotic assay.  
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Indeed, the S. aureus strains K1801/10, 6850 and K70058396 showed 70% of Annexin V 
positive cells for all three cytotoxic isolates.  The number of PI and double stained positive 
cells did not show significant changes with any of the strains compared to the negative 
control. Data indicates that apoptosis is the main method of cell death. In contrast, the non-
cytotoxic strain 8325-4 lacked the ability to induce any apoptotic changes when compared 
to the mock treatment. Hydrogen peroxide-induced  a significant increase in late apoptosis 
as seen by an increase of double positive cells (Fig. 17). 
 
Figure 17. Annexin V/PI apoptosis assay by flow cytometry. The percentage of Annexin V, PI and double 
positive endothelial cells was determined after infection with S. aureus strains (MOI of 50) at 18 hours post-
infection. The data shown is the mean from four independent experiments, indicated as ± SEM. The p-values 
related to mock-treated control (bold star). *=p≤0.05, **=p≤0.005, ***=p≤0.005, ns= not significant. 
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To further confirm the induction to apoptosis by cytotoxic S. aureus strains, we 
performed a caspase-3 apoptosis assay in living cells by adding a membrane permeable 
caspase-3 substrate. Endothelial cells were infected with the test strains and the caspase-3 
substrate was added for 30 minutes at room temperature before formaldehyde fixation and 
microscopic analyses (Fig. 18). Unfortunately, the caspase substrate needs to be added at 
room temperature in accordance with the manufacturer’s instructions. It is well known that 
down-regulation of temperature from 37°C to room temperature (about 21°C) can cause a 
partial loss of cell-cell adhesion that was observed in all of our cell cultures (Fig. 19). In the 
case of the positive control sample, cells were treated with 1 mM hydrogen peroxide for 
one hour before the culture medium and lysostaphin were applied to every test sample (Fig. 
18).  
 
Figure 18. The scheme of caspase-3 apoptotic assay. 
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The cytotoxic S. aureus strains K1801/10, 6850, K70058396 and hydrogen peroxide 
treatments induced caspase-3 activation, which led to cytosolic caspase-3 substrate 
cleavage and translocation of free nuclear dye into the nuclei of the endothelium. 
Therefore, the fluorescent signal in the nucleus corresponds to caspase 3 active cleavage of 
the caspase-3 substrate. To quantify the intensity of the nuclei fluorescence signal, we used 
ImageJ Software. For quantification, we used three randomly acquired, 40x magnification, 
fields of view of each sample for the four independent experiments (Fig. 20) giving a total of 
12 fields in total each containing 30-50 cells. 
 
Figure 20. Caspase-3 apoptosis assay. The integrated signal density of caspase-3 cleaved substrate was 
multiplied by number of fluorescent events. The data shown is the mean from four independent experiments, 
indicated as ± SEM. The p-values related to mock-treated control (bold star). *=p≤0.05, **=p≤0.01, 
***=p≤0.005, ns= not significant. 
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Data demonstrates that cytotoxic S. aureus strains K1801/10, 6850 and K70058396 prefer 
to induce early apoptosis in endothelial cells while strains ls 8325-4, K9657/04 and 
K2900/10 appear to lack this ability.  
 
3.6. Global transcriptome analyses of HUVECs infected with 
different isolates of S. aureus 
S. aureus strains demonstrated strain-specific differences in their interactions with the 
endothelium. Strains varied greatly in their inflammatory result, influence of apoptotic 
properties and translocation behavior. To identify mechanisms and signaling pathways that 
might be involved in these processes and result in these variations, we performed a whole 
genome transcriptome analysis using Illumina DNA-microarray technology. 
 
3.6.1 The study of gene expression and experimental design 
S. aureus strain selection was based on the pathophysiological behaviors exemplified in 
each as described in chapter 3.2. For the transcriptome analyses, we infected  HUVEC and 
isolated mRNA at 7 hours post-infection, respectively (Fig. 21). The treatment with 100 
ng/ml of TNF-α was used as a positive control. The isolated mRNA was used for reference 
gene study prior to the microarray experiment and it’s quality was checked by an optical 
density ratio test. 
 
 
Figure 21. The scheme of HUVEC infection for expression studies. 
Prior the microarray assay, we tested expression response of reference genes ICAM-1, 
VCAM-1 and E-selectin by RT-qPCR. These genes are already known to be differentially 
upregulated in endothelium upon S. aureus infection as well as after TNF-α stimulation.  
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Figure 22. Differential expression of endothelial adhesion molecules upon S. aureus infection or TNF-α 
treatment. Data shown is the mean from 5 independent experiments, as indicated, ± SEM. The p-values were 
determined related to a mock-infected control, respectively. *=p≤0.05, **=p≤0.005, ***=p≤0.0005, ns=not 
significant 
S. aureus infection and TNF-α treatment caused high upregulation of endothelial pro-
inflammatory response genes in reference to ICAM-1, VCAM-1 and E-selectin expression 
(Fig. 22). The result of the expression of pro-inflammatory response genes was considered 
during experimental design and was used to validate the reliability of the experiments. 
The microarray experiment (Fig. 23) was performed using isolated HUVEC mRNA after 
infection with six selected S. aureus strains and TNF-α treatment. HUVEC were infected and 
mRNA was isolated in accordance to protocol illustrated in figure 24 (Fig. 24). 
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Figure 23. Microarray experiment 
 
3.7. Microarray controls 
3.7.1 Microarray internal controls 
Transcriptome analysis was performed using DNA-microarray technology (Illumina) in 
cooperation with the Institute of Human Genetics in Münster, headed by Prof. Dr. Monika 
Stoll. Experimental procedures were performed according to the scheme (Fig. 23). For the 
transcriptome analysis, a HumanHT-12 v4 Expression BeadChip microarray detection chip 
was used. 
Prior to expression, data analyses’ internal quality controls governing microarray 
performance were considered. The microarray internal controls represent a technical note, 
which describes the concept; metrics and techniques ensure the quality of collected data. 
Based on the expected quality standards, a decision was made concerning further analyses 
(Illumina, 2010) (Table 6).  
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Control Metric Expected value Notes** 
Hybridization Controls* High > Medium > Low 
There are three spikes in concentrations of Cy3-
labeled oligos with perfect matches to control 
oligos on the BeadChip.  The data will be 
considered acceptable if the signal intensities from 
these hybridization controls are present at low, 
medium, and high signal levels, respectively. 
Low Stringency* 
PM (perfect match) > 
MM2 (mismatch) 
MM2 (oilgo with two mismatches to a control oligo 
on the beadchip) and PM (oligo with a perfect 
match to a control oligo on the beadchip). These 
controls provide a way of judging if the stringency 
is too low.  Ideally, the ratio of PM to MM2 should 
be higher. If this ratio is low then the stringency is 
not high enough.   
Biotin and High Stringency* High 
The biotin control is biotin labeled oligo that binds 
to an oligo on the BeadChip and stains with 
Streptavidin-Cy3.  The low intensity for the biotin 
control indicate complications with the staining 
procedure.   
Negative Controls 
(Background and Noise) 
Low 
The negative controls provide a measure for the 
stringency of the hybridization which depends on 
various conditions such as temperature, 
formamide concentration, high temperature wash 
and other factors. The data will be considered 
acceptable if the signal for the negative signal is 
very low or absent. 
Gene Intensity 
(Housekeeping and All 
Genes) 
Higher than Background 
(Housekeeping > All 
Genes) 
Gene intensity is used to evaluate the quality of 
the samples.  The signal level of housekeeping 
genes should be a very high when compared to the 
signal of all genes. 
Labeling and Background 
If used, 
Labeling > Background;  
Otherwise, 
Labeling ≈ Background 
Labelled controls come from external nucleic acids 
(RNA from Bacillus sp.) that are spiked into the 
reverse transcription reaction.  These controls 
track the efficiency of reverse transcription 
reaction and staining.  The labeling and 
background controls should have approximately 
equal and low signal intensities. The background 
value provides a measures of the signal intensity 
resulting from the auto florescence of the surface 
array and nonspecific binding of target or stain 
molecules. High levels of background cause an 
overall loss of sensitivity in the experiment.   
 
Table 4. Microarray quality controls. * Sample-independent controls. ** Description of internal controls 
((YCGA), 2015) 
Internal controls are distinguished as sample-dependent and sample-independent 
controls (Table 4). Sample-independent controls evaluate BeadChip and reagent 
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performance, efficiency of hybridization and the staining process. The sample-dependent 
controls are used to evaluate sample quality and performance. They include negative 
controls, gene intensity and labeling as well as the background controls (Illumina, 2010). The 
specific report on microarray internal controls is illustrated in figure 24 (Fig. 24). The 
reliability of each internal control parameter corresponded to the manufacturer´s 
requirements (Table 6).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24. Control summary plot. A. Hybridization controls; B. Biotin and high stringency; C. Low stringency; D. 
Negative controls ; E. Gene intensity (Housekeeping genes and All genes); F. Labeling and background.   
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3.7.2. Determining sample similarity by scatter plotting.  
The scatter plots compare the data on transcription expression levels between two 
samples and represents the homogeneity of replicate expression. Biological replicates 
should exhibit similar transcript levels. The linear correlation values (r²) was > 0.95 in all 
samples for hybridization replicates (Illumina, 2010) (Fig. 25). 
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Figure 25. The data quality diagnosis by scatter plot. A.- P. Plotted detection values for sample replicates.   
 
The control parameters’ assessment of the performed microarray confirmed the high 
validity and reliability of the obtained data. 
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3.7.3. Validation of microarray data by RT-qPCR  
One of the most important steps to validate microarray results is to confirm expression 
data with RT-qPCR. This tactic is most frequently used as an independent gene expression 
profiling method. 
The mRNA used for microarray analysis data-validation was isolated through an identical 
treatment protocol as previously described for microarray and reference gene analyses (Fig 
11). Based on the microarray analysis data, we selected 30 genes from each of the three 
functional groups for validation. The selected genes are characteristic of the following 
functional groups: a) apoptosis (6 genes, Fig. 26); b) immune response (13 genes, Fig. 27), c) 
cytoskeleton/development (9 genes, Fig. 28).  
 
RT-PCR validates gene array data sets 
             Apoptotic genes 
 
 
 
 
 
 
 
 
 
Figure 26. Expression of the selected endothelial genes involved in endothelial cell death by RT-qPCR. The data 
shown is the mean from minimum three independent experiments, indicated as ± SEM. The p-values were 
determined related to mock-infected control. *=p≤0.05,**=p≤0.005, ***=p≤0.0005, ns=not significant. 
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Immune response gene 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Expression of the selected endothelial genes involved in innate 
immune response by RT-qPCR. The data shown is the mean from minimum 
three independent experiments, indicated as ± SEM. The p-values were 
determined related to mock-infected control. *=p≤0.05,**=p≤0.005, 
***=p≤0.0005, ns=not significant 
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Cytoskeleton/Development  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Validation by RT-qPCR expression confirmed that 95% of the genes display the same 
expression pattern as seen in the microarray analysis. Due to the higher sensitivity of RT-
qPCR, we also saw changes in differential gene expression for the nine transcripts with 
Figure 28. Expression of the selected 
endothelial genes involved in 
cytokinesis/development by RT-
qPCR. The data shown is the mean 
from minimum three independent 
experiments, indicated as ± SEM. 
The p-values were determined 
related to mock-infected control. 
*=p≤0.05,**=p≤0.005, 
***=p≤0.0005, ns=not significant 
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strains K9657/04 and K2900/10 demonstrating a much weaker response when compared to 
the other four isolates (Fig. 26-28).  
The high correlation of the microarray data and the values obtained from RT-qPCR 
designate that this experiment has yielded reliable data which can be used for further 
bioinformatical data analyses. 
 
3.7.4. Principal component analysis 
Principal component analysis (PCA) is a statistical method that allows for the visualization 
and investigation of variability in a given dataset. This is achieved by assigning so-called 
principal components, representing the principal directions along which data variation is 
highest (Powell V., 2014). When applied to microarray data, the PCA identifies the set of 
genes with the greatest variability, which is invaluable in these experiments as differential 
expression between few treatments should be investigated.   
We used PCA as a first approach to analyze gene expression data before applying 
threshold or any other sorting approach (Fig. 28).  The gene set assigned to PC1 seems best 
to reflect differences between the strains, grouping them in the separate clusters with only 
few intersecting points. Interestingly, areactive strains are grouped together with the 
negative control. The pro-inflammatory strain 8325-4, on the other hand, is grouped close 
to the positive control, pro-inflammatory mediator TNF-α. Data analysis assigns PC1 gene 
ontology (GO)-terms including response to type I interferon and response to a virus, 
associated with STAT- and IRF-dependent transcription. 
PC2 appears to reflect the differences between endothelial cell cultures isolated from 
different donors, thereby pulling data from separate replications of the same treatment 
along the y-axis. PC2 is assigned GO-terms including translation, cell adhesion and wound 
healing, which might be associated with transcription factors such as SPII, GABPA, Egr1 (Fig. 
33).  
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Figure 28. Principal component analysis of microarray data. Components ranged from the largest to the 
smallest variations; the first two components are plotted. Three replications of the same treatment are 
encircled.  
The PCA results confirmed strain-specific differences in the transcriptional responses of 
the infected endothelium. 
 
3.8. Microarray results 
3.8.1. Differential expression of HUVECs infected with different S. aureus strains  
The overall result of the microarray with all treatments showed significant differences in 
expression of 4968 of the 34695 HUVEC genes screened. In the following analysis, we 
included the expression data of 875 genes. 505 of these were significantly up-regulated to 
twice their original level of expression and 370 were significantly down-regulated to less 
than 60% of their original level of expression by at least one of the treatments.  
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The statistics for obtained data were analyzed by the statistical test package of 
GenomeStudio Software (Illumina). Gene expression was considered statistically significant 
when P-values were lower than 0.05. The statistically significant data showed an 
upregulation to more than twice the original level of expression and a downregulation of 
less than 60% of their original level of expression; values that were used in further analyses.   
 
Figure 29. Number of HUVEC´ differentially expressed genes infected with S. aureus isolates and TNF-α treated 
in comparison with mock infection. In the red box is the number of differentially expressed genes for the 
strains that did not affect endothelial gene expression response.  The data represents three independent 
experiments. The p-values were determined in relation to differential expression of mock-treated control and 
detection p-values respectively. The differential p-value: p≤0.05. The detection p-value: p≤0.05. 
The strain K1801/10 induced the differential expression of 610 transcripts. Strains 8325-4 
and 6850 caused relatively high levels of gene expression changes to occur, including a 
respective 278 and 224 differentially expressed genes. Strain K70058396 changed the 
expression levels of 98 genes.  
A similar gene expression trait is also true for the differential expression of unique 
transcripts. Unique genes are defined as genes that change expression only during a single 
treatment such as infection or TNF-α. The highest number of unique gene expression 
changes was observed for strain K1801/10 – 336 transcripts and the lowest for strain 
K70058396 with only 10 genes. Strains K2900/10 and K9657/04 did not show expression 
changes for almost any of the transcripts, and were therefore excluded from further group 
analyses (Fig. 29).  
TNF-α treatment induced a differential expression of 390 gene transcripts with high 
levels of unique gene expression, namely 240 gene transcripts.  
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3.8.2. Differential expression of HUVEC innate immunity genes 
In the next stage, the transcriptome of all differentially expressed genes was grouped 
using functional clustering approach. Particularly, “The Database for Annotation, 
Visualization and Integrated Discovery” (DAVID) v6.7 software was used in which clusters 
were selected in accordance to Fisher exact p-value≤0.05 based on their enrichment score 
(Huang da et al., 2009b; Huang da et al., 2009a). The Fisher exact p-value determines 
whether a particular user gene list is associated (enriched) for a particular signaling pathway 
when compared to the sets of genes taken-up by random chance. Additionally, the online 
database “GeneCards” (for functional annotation of genes) was used to verify particular 
gene functions (GeneCards, 1996-2015 ). Gene lists, analyzed by these two approaches, 
were divided into four main groups: genes related to innate immunity (Table 5), apoptotic 
genes (Table 6), genes related to cytokinesis and development (Table 7) and genes encoding 
transcription factors and signaling molecules (Table 8). 
Gene 
symbol 
Gene bank 
accession 
number Full gene name 
Fold 
change 
TNF-α 
treated 
Fold 
change 
K1801/10 
Fold 
change 
6850 
Fold 
change 
K70058396 
Fold 
change 
8325-4 
  
  
Pos. 
Control S. aureus strains  
Genes related to innate immunity 
 Cytokines and chemokines 
     
  
  
      
  
CCL2 NM_002982.3 chemokine (C-C 
motif) ligand 2 21,33 9,87 7,97 6,79 7,33 
CCL20 NM_004591.1 chemokine (C-C 
motif) ligand 20 22,86 3,88 2,45 NS NS 
CCL5 NM_002985.2 chemokine (C-C 
motif) ligand 5 2,1 17,77 10,9 1,95 NS 
CCL8 NM_005623.2 chemokine (C-C 
motif) ligand 8 NS 11,43 8,84 NS 19,61 
CX3CL1 NM_002996.3 chemokine (C-X3-C 
motif) ligand 1 71,43 25,29 23,4 5,62 21,97 
CXCL1 NM_001511.1 chemokine (C-X-C 
motif) ligand 1 
(melanoma 
growth stimulating 
activity, alpha) 10,17 9,11 3,55 5,45 NS 
CXCL10 NM_001565.1 chemokine (C-X-C 
motif) ligand 10 16,7 84,8 64,62 12,32 107,3 
CXCL2 NM_002089.1 chemokine (C-X-C 
motif) ligand 2 9,25 11,12 4,79 NS NS 
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CXCL9 NM_002416.1 chemokine (C-X-C 
motif) ligand 9 NS 4,5 2,26 NS 8,49 
IL10 NM_000572.2 interleukin 10 NS 3,85 2,69 NS NS 
IL6 NM_000600.1 interleukin 6 
(interferon, beta 
2) NS 13,3 NS NS NS 
IL8 NM_000584.2 interleukin 8 25,97 10,11 7,42 NS NS 
  
      
  
Adhesion molecules 
     
  
  
      
  
CD47 NM_00102508
0.1 
CD47 molecule 
1,78 NS 1,5 NS 2,22 
CD93 NM_012072.2 CD93 molecule 0,79 0,59 0,83 0,85 NS 
CEACAM1 NM_00102491
2.1 
carcinoembryonic 
antigen-related 
cell adhesion 
molecule 1 (biliary 
glycoprotein) NS 3,47 2,96 NS 2,7 
CLEC14A NM_175060.1 C-type lectin 
domain family 14, 
member A 0,61 0,59 0,68 0,75 NS 
ICAM1 NM_000201.1 intercellular 
adhesion molecule 
1 37,43 5,03 3,49 NS 3,53 
LGALS8 NM_201544.1 lectin, galactoside-
binding, soluble, 8 NS NS NS NS 2,07 
SDC4 NM_002999.2 syndecan 4 2,39 2,37 1,75 1,25 NS 
SELE NM_000450.1 selectin E 50,35 8,1 NS NS NS 
  
      
  
Antigen presentation/reseptors 
    
  
  
      
  
CD274 NM_014143.2 CD274 molecule NS 2,42 1,77 NS 1,98 
CD68 NM_001251.2 CD68 molecule NS 1,81 1,69 NS 2,41 
CD83 NM_004233.3 CD83 molecule 11,13 3,7 3,35 NS NS 
COLEC12 NM_130386.1 collectin sub-
family member 12 0,79 0,58 NS 0,68 0,75 
IFI30 NM_006332.3 interferon, 
gamma-inducible 
protein 30 NS 1,48 1,27 NS 2,44 
KLRG1 NM_005810.3 killer cell lectin-
like receptor 
subfamily G, 
member 1 0,53 0,57 NS NS NS 
PSMB10 NM_002801.2 proteasome 
(prosome, 
macropain) 
subunit, beta type, 
10 1,72 NS NS NS 2,19 
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PSMB8 NM_148919.3 proteasome 
(prosome, 
macropain) 
subunit, beta type, 
8 (large 
multifunctional 
peptidase 7) 1,22 1,85 1,67 NS 3,02 
PSMB9 NM_002800.4 proteasome 
(prosome, 
macropain) 
subunit, beta type, 
9 (large 
multifunctional 
peptidase 2) 1,35 1,68 1,62 NS 3,13 
PTX3 NM_002852.2 Pentraxin 3, Long 3,76 2,34 2,06 2,49 NS 
TAP1 NM_000593.5 transporter 1, 
ATP-binding 
cassette, sub-
family B 
(MDR/TAP) 5,9 6,97 6,2 2,93 11,59 
TAP2 NM_000544.3 transporter 2, 
ATP-binding 
cassette, sub-
family B 
(MDR/TAP) 1,46 1,36 1,23 NS 2,63 
TLR3 NM_003265.2 toll-like receptor 3 NS 1,7 1,67 NS 3,38 
  
      
  
Complement 
     
  
  
      
  
CFB NM_001710.4 complement 
factor B NS 2,3 NS NS NS 
F3 NM_001993.2 coagulation factor 
III 
(thromboplastin, 
tissue factor) 4,79 2,73 NS NS NS 
PLAUR NM_002659.2 plasminogen 
activator, 
urokinase receptor NS 2,73 2,25 1,86 NS 
SERPINE1 NM_000602.1 serpin peptidase 
inhibitor, clade E 
(nexin, 
plasminogen 
activator inhibitor 
type 1), member 1 3,98 3,19 2,62 NS NS 
  
      
  
Interferon response 
     
  
  
      
  
EPSTI1 NM_033255.2 epithelial Stromal 
Interaction Protein 
1 NS 12,62 12,44 5,32 27,21 
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GBP1 NM_002053.1 guanylate binding 
protein 1, 
interferon-
inducible, 67kDa 4,37 8,81 7,6 2,35 16,99 
GBP2 NM_004120.3 guanylate binding 
protein 2, 
interferon-
inducible 1,73 NS 1,77 NS 3,55 
GBP4 NM_052941.2 guanylate binding 
protein 4 1,8 3,31 2,49 NS 5,09 
GBP5 NM_052942.2 guanylate binding 
protein 5 NS 3,17 1,84 NS 3,55 
FAM111A NM_022074.2 family with 
sequence 
similarity 111, 
member A 1,32 1,5 NS NS 2,04 
FAM46C NM_017709.2 family with 
sequence 
similarity 46, 
member C 1,26 1,36 NS NS 2,13 
HERC5 NM_016323.1 hect domain and 
RLD 5 NS 13,53 11,11 3,12 13,69 
HERC6 NM_00101300
5.1 
hect domain and 
RLD 6 NS 4,41 3,74 1,61 7,13 
IFI16 NM_005531.1 interferon, 
gamma-inducible 
protein 16 NS 1,68 1,93 NS 2,69 
IFI35 NM_005533.2 interferon-induced 
protein 35 1,42 4,29 3,33 NS 10,56 
IFI44 NM_006417.2 interferon-induced 
protein 44 NS 6,13 5,93 2,94 8,36 
IFI44L NM_006820.1 interferon-induced 
protein 44-like NS 6,88 5 2,58 16,66 
IFI6 NM_002038.2 interferon, alpha-
inducible protein 6 NS NS NS NS 3,28 
IFIH1 NM_022168.2 interferon induced 
with helicase C 
domain 1 4,64 9,86 8,91 2,85 17,38 
IFIT1 NM_001548.2 interferon-induced 
protein with 
tetratricopeptide 
repeats 1 NS 44,67 40,92 18,71 45,26 
IFIT2 NM_001547.3 interferon-induced 
protein with 
tetratricopeptide 
repeats 2 2,77 41,91 41,21 16,29 41,57 
IFIT3 NM_00103168
3.1 
interferon-induced 
protein with 
tetratricopeptide 
repeats 3 2,11 26,83 20,86 7,7 29,92 
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IFIT5 NM_012420.1 interferon-induced 
protein with 
tetratricopeptide 
repeats 5 NS 2,48 2,91 2,17 4 
IFITM1 NM_003641.2 interferon-induced 
transmembrane 
protein 1 (9-27) NS 5,71 5,42 2,65 9,92 
IFNB1 NM_002176.2 interferon, beta 1, 
fibroblast NS 44,8 18,6 NS NS 
ISG15 NM_005101.1 ISG15 ubiquitin-
like modifier NS 16,48 12,27 6,1 18,43 
ISG20 NM_002201.4 interferon 
stimulated 
exonuclease gene 
20kDa 5,26 10,88 9,65 NS 15 
MX1 NM_002462.2 myxovirus 
(influenza virus) 
resistance 1, 
interferon-
inducible protein 
p78 (mouse) NS 7,85 7,08 4,05 10,92 
MX2 NM_002463.1 myxovirus 
(influenza virus) 
resistance 2 
(mouse) NS 5,31 NS NS 14,52 
TRIM21 NM_003141.3 tripartite motif-
containing 21 2,12 2,9 3,11 1,92 5,57 
TRIM22 NM_006074.2 tripartite motif-
containing 22 1,44 1,84 1,7 NS 3,63 
TRIM25 NM_005082.4 tripartite motif-
containing 25 NS NS 1,59 NS 3,03 
TRIM38 NM_006355.2 tripartite motif-
containing 38 0,87 1,65 1,29 NS 2,13 
TRIM56 NM_030961.1 tripartite motif-
containing 56 1,76 1,86 1,53 1,28 2,17 
USP18 NM_017414.3 ubiquitin specific 
peptidase 18 NS 6,49 5,51 2,33 10,63 
  
      
  
Other genes involved in immune response 
    
  
  
      
  
ANGPT2 NM_00111888
8.1 
angiopoietin 2 
NS 0,59 NS NS NS 
APOL3 NM_030644.1 apolipoprotein L, 3 4,68 NS 2,04 NS 5,01 
CH25H NM_003956.2 cholesterol 25-
Hydroxylase 0,68 4,9 2,27 NS NS 
GCH1 NM_000161.2 GTP 
cyclohydrolase 1 2,42 2,94 2,85 1,44 4,1 
IDO1 NM_002164.4 indoleamine 2,3-
dioxygenase 1 1,92 7,83 3,62 1,25 20,65 
LOC10012 XM_001721430 hypothetical NS 2,53 NS NS NS 
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9362 .1 LOC100129362 
LRRC33 NM_198565.1 leucine rich repeat 
containing 33 0,35 0,56 0,65 NS 0,63 
OAS1 NM_002534.2 2',5'-
oligoadenylate 
synthetase 1, 
40/46kDa NS 6,43 4,3 2,13 9,89 
OAS2 NM_002535.2 2'-5'-
oligoadenylate 
synthetase 2, 
69/71kDa NS 7,94 6,78 3,05 13,28 
OAS3 NM_006187.2 2'-5'-
oligoadenylate 
synthetase 3, 
100kDa NS 3,48 2,85 1,6 6,84 
OASL NM_003733.2 2'-5'-
oligoadenylate 
synthetase-like NS 49,95 29,84 6,08 39,17 
PTGS2 NM_000963.1 prostaglandin-
endoperoxide 
synthase 2 
(prostaglandin 
G/H synthase and 
cyclooxygenase) NS 9,25 6,39 NS 3,9 
RFTN1 NM_015150.1 raftlin, lipid raft 
linker 1 NS NS 0,58 NS NS 
RFTN2 NM_144629.1 raftlin family 
member 2 0,58 NS NS 0,56 NS 
SP100 NM_00108039
1.1 
SP100 nuclear 
antigen NS 1,96 1,46 NS 2,78 
SP110 NM_080424.1 SP110 nuclear 
body protein NS 3,69 3,49 2,02 7,8 
SPAG9 NM_172345.1 sperm associated 
antigen 9 1,51 2,19 2,22 NS NS 
Table 5. The HUVEC expression of the immune response genes upon infection with S. aureus blood isolates. 
The genes were divided in several subgroups in accordance to their specific function. Each gene symbol 
corresponds with the full gene name; “Gene Bank” accession number; and fold of transcriptional change for 
every S. aureus isolates and TNF-alpha treatment. The significantly upregulated genes are shown in red; the 
significantly downregulated genes in blue; and the not significantly expressed genes in grey. The data shown is 
the mean from three independent experiments. The p-values were determined respectively to differential 
expression of mock-treated control and detection p-values. The differential p-value: p≤0.05; ns= not 
significant. The detection p-value: p≤0.05; ns= not significant. 
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3.8.3. Differential expression of  cell death-related genes in endothelium 
Gene 
symbol 
Gene bank 
accession 
number Full gene name 
Fold 
change 
TNF-α 
treated 
Fold 
change 
K1801/10 
Fold 
change 
6850 
Fold 
change 
K70058396 
Fold 
change 
8325-4 
  
Pos. 
Control S. aureus strains  
Apoptosis 
Pro-apoptotic genes 
     
  
  
      
  
AXUD1 NM_033027.2 Cysteine-Serine-
Rich Nuclear 
Protein 1 2,78 7,48 3,4 2,45 2,52 
ARHGEF6 NM_004840.2 Rac/Cdc42 
guanine 
nucleotide 
exchange factor 
(GEF) 6 0,67 0,52 0,59 0,62 NS 
BCL3 NM_005178.2 B-cell 
CLL/lymphoma 3 3,26 2,39 1,67 1,5 NS 
BCL6 NM_001706.2 B-cell 
CLL/lymphoma 6 NS 2,96 1,82 NS NS 
CASP1 NM_033292.2 caspase 1, 
apoptosis-related 
cysteine peptidase 
(interleukin 1, 
beta, convertase) NS NS NS NS 3 
CASP7 NM_033338.4 caspase 7, 
apoptosis-related 
cysteine peptidase 1,44 1,62 1,69 1,22 2,19 
DUSP1 NM_004417.2 dual specificity 
phosphatase 1 NS 3,43 2,75 NS NS 
PMAIP1 NM_021127.1 phorbol-12-
myristate-13-
acetate-induced 
protein 1 1,98 11,61 8,8 2,17 5,03 
PLEKHF1 NM_024310.2 pleckstrin 
homology domain 
containing, family 
F (with FYVE 
domain) member 
1 0,75 2,18 2,57 1,39 2,83 
PHLDA1 NM_007350.3 pleckstrin 
homology-like 
domain, family A, 
member 1 2,63 4,23 2,63 2,09 NS 
RIPK1 NM_003804.3 receptor (TNFRSF)-
interacting serine-
threonine kinase 1 NS 2,46 1,66 NS 2,42 
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TXNIP NM_006472.1 thioredoxin 
interacting protein 0,36 NS 1,94 NS 2,85 
TNFSF10 NM_003810.2 tumor necrosis 
factor (ligand) 
superfamily, 
member 10 NS 5,45 3,98 NS 9,69 
TP53INP1 NM_033285.2 tumor protein p53 
inducible nuclear 
protein 1 NS 0,45 0,55 0,69 0,77 
   
     
  
Anti-apoptotic genes   
    
  
   
     
  
ACVR1 NM_001105.2 activin A receptor, 
type I NS 0,59 0,71 0,71 NS 
ANGPTL4 NM_0010396
67.1 
angiopoietin-like 4 
NS 10,07 NS 5,45 NS 
BIRC3 NM_182962.1 baculoviral IAP 
repeat-containing 
3 10,4 6 4,33 NS NS 
CBX4 NM_003655.2 chromobox 
homolog 4 (Pc 
class homolog, 
Drosophila) NS 2,34 1,82 1,3 2,31 
MCL1 NM_021960.3 myeloid cell 
leukemia 
sequence 1 (BCL2-
related) 1,6 2,83 2,43 1,7 2,21 
NR4A2 NM_006186.2 nuclear receptor 
subfamily 4, group 
A, member 2 NS 3,46 3,14 NS NS 
NUAK1 NM_014840.2 NUAK family, 
SNF1-like kinase, 1 0,22 0,4 0,42 0,64 0,56 
NUAK2 NM_030952.1 NUAK family, 
SNF1-like kinase, 2 3,62 2,34 1,52 NS NS 
PARP10 NM_032789.1 poly (ADP-ribose) 
polymerase family, 
member 10 NS 1,79 1,56 NS 3,2 
PARP12 NM_022750.2 poly (ADP-ribose) 
polymerase family, 
member 12 1,36 2,62 2,3 NS 4,27 
PARP14 NM_017554.1 poly (ADP-ribose) 
polymerase family, 
member 14 3,13 2,9 1,96 NS 5,24 
PARP9 NM_031458.1 poly (ADP-ribose) 
polymerase family, 
member 9 1,45 3,66 3,44 2,03 7,13 
TIPARP NM_015508.2 TCDD-inducible 
poly(ADP-ribose) 
polymerase 0,6 4,08 3,81 1,55 3,02 
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TNFAIP3 NM_006290.2 tumor necrosis 
factor, alpha-
induced protein 3 16,46 11,49 5,15 NS NS 
        Apoptosis regulatory genes
     
  
   
     
  
C8orf4 NM_020130.2 chromosome 8 
open reading 
frame 4 10,55 8,38 4,05 NS NS 
C21orf63 NM_058187.3 chromosome 21 
open reading 
frame 63 2,28 2,44 1,83 1,8 NS 
CCNA1 NM_003914.2 cyclin A1 NS 2,97 2,64 NS NS 
DCP1A NM_018403.2 DCP1 decapping 
enzyme homolog 
A (S. cerevisiae) 1,34 2,28 1,93 1,26 2,18 
DDIT4 NM_019058.2 DNA-damage-
inducible 
transcript 4 0,48 1,79 NS NS 0,51 
DHX58 NM_024119.1 DEXH (Asp-Glu-X-
His) box 
polypeptide 58 1,6 2,29 1,98 NS 3,93 
DUSP19 NM_080876.2 dual specificity 
phosphatase 19 NS 7,4 5,04 1,77 7,22 
DUSP5 NM_004419.3 dual specificity 
phosphatase 5 NS 2,27 2,59 1,81 2,43 
EIF2AK2 NM_002759.1 eukaryotic 
translation 
initiation factor 2-
alpha kinase 2 NS 2,87 2,78 NS 4,37 
FAM188A NM_024948.2 chromosome 10 
open reading 
frame 97 NS 0,6 0,77 NS 0,82 
GADD45B NM_015675.1 growth arrest and 
DNA-damage-
inducible, beta NS 4,3 2,31 NS NS 
GDF15 NM_004864.1 growth 
differentiation 
factor 15 NS 2,7 NS 1,84 NS 
HES1 NM_005524.2 hairy and 
enhancer of split 
1, (Drosophila) 0,46 2,29 NS NS NS 
HK2 NM_000189.4 hexokinase 2 
pseudogene; 
hexokinase 2 NS 1,56 2,28 1,79 1,53 
INDO NM_002164.3 indoleamine 2,3-
dioxygenase 1 1,93 7,94 NS 1,24 19,16 
KIAA0196 NM_014846.2 KIAA0196 0,7 0,58 0,62 0,76 NS 
MLKL NM_152649.1 mixed lineage 
kinase domain-like NS 2,43 2,26 1,48 3,99 
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NLRP8 NM_176811.2 NLR family, pyrin 
domain containing 
8 NS 2,12 NS NS NS 
PLSCR1 NM_021105.1 phospholipid 
scramblase 1 NS 3 2,28 NS 4,1 
PPP1R15A NM_014330.2 protein 
phosphatase 1, 
regulatory 
(inhibitor) subunit 
15A 1,52 4,15 2,27 1,68 1,62 
PRMT6 NM_018137.1 protein arginine 
methyltransferase 
6 NS 0,55 0,76 NS NS 
REEP1 NM_022912.1 receptor accessory 
protein 1 0,63 0,55 0,66 0,6 0,72 
SLC40A1 NM_014585.3 solute carrier 
family 40 (iron-
regulated 
transporter), 
member 1 0,52 0,29 0,45 0,42 NS 
TRIM69 NM_080745.3 tripartite motif-
containing 69 NS 2,21 1,5 NS NS 
VIP NM_003381.2 vasoactive 
intestinal peptide NS 2,3 3,07 1,64 NS 
XAF1 NM_199139.1 XIAP associated 
factor 1 1,26 2,75 2,45 1,61 5,72 
Table 6. The HUVEC expression of genes related to cell death upon infection with S. aureus blood isolates. 
Genes are divided in several subgroups: pro-, anti-apoptotic and regulatory cell death genes. Each gene symbol 
corresponds with the full gene name; “Gene Bank” accession number; and fold of transcriptional change for 
every S. aureus isolate and TNF-alpha treatment. The significantly upregulated genes are shown in red; the 
significantly downregulated genes in blue; and the not significantly expressed genes in grey. The data shown is 
the mean from three independent experiments. The p-values were determined respectively to differential 
expression of mock-treated control and detection p-values. The differential p-value: p≤0.05; ns= not 
significant. The detection p-value: p≤0.05; ns= not significant. 
 
The data indicates that the strain-specific differential expression of HUVEC genes related 
to cell death showed the strongest induction with cytotoxic S. aureus K1801/10 isolate (55 
genes) and 6850 isolate (34 genes). However, the cytotoxic strain K70058396 only affected 
the expression of nine gene transcripts. The non-cytotoxic strain 8325-4 caused a change in 
expression of only 29 genes.  
This outcome raised the question as to which factors and what mechanism could cause 
such a difference and change the expression levels of cell death-related genes so 
dramatically during strain-specific S. aureus-induced infection. To answer this question we 
conducted a comprehensive analysis of S. aureus-induced endothelial cell death regarding 
HUVEC gene expression, which is described in the following chapters.  
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3.8.4. Differential expression of HUVEC cytoskeleton and developmental 
genes 
The genes of cytokinesis & development (Table 7) and transcription factors & signaling 
groups (Table 8) are listed below. These groups might hold important information 
concerning the mechanisms and signaling pathways involved in cytoskeleton regulation and 
infection signaling during pathophysiological infection changes in endothelium.  
 
Gene 
symbol 
Gene bank 
accession 
number Full gene name 
Fold 
change 
TNF-α 
treated 
Fold 
change 
K1801/10 
Fold 
change 
6850 
Fold 
change 
K70058396 
Fold 
change 
8325-4 
  
Pos. 
Control S. aureus strains  
Cytokinesis and development 
  
      
  
Cytoskeleton/adhesion/migration 
    
  
  
      
  
ACTA2 NM_001613.1 actin, alpha 2, 
smooth muscle, 
aorta NS 2,28 1,81 1,45 NS 
AGGF1 NM_018046.3 angiogenic factor 
with G patch and 
FHA domains 1 0,75 0,57 0,73 0,75 NS 
C16orf30 NM_024600.1 TMEM204 
(Transmembrane 
Protein 204) 0,63 0,54 0,62 0,62 NS 
CALM1 NM_006888.2 calmodulin 3 
(phosphorylase 
kinase, delta); 
calmodulin 2 
(phosphorylase 
kinase, delta); 
calmodulin 1 
(phosphorylase 
kinase, delta) NS 0,56 NS NS NS 
CLDN11 NM_005602.4 claudin 11 NS NS NS 2,28 NS 
CLDN23 NM_194284.1 claudin 23 NS NS NS NS 3,13 
CNKSR3 NM_173515.2 membrane 
associated 
guanylate kinase, 
WW and PDZ 
domain containing 
1; CNKSR family 
member 3 6,11 2,78 3,33 1,53 NS 
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COL3A1 NM_000090.2 collagen, type III, 
alpha 1 NS 0,46 NS NS NS 
DIXDC1 NM_0010379
54.2 
DIX domain 
containing 1 0,6 0,56 0,62 0,68 0,75 
FAM107A NM_007177.1 family with 
sequence similarity 
107, member A NS NS NS NS 2,16 
FLNC NM_001458.2 filamin C, gamma 
(actin binding 
protein 280) NS 1,53 1,9 2,08 NS 
FLRT2 NM_013231.4 fibronectin leucine 
rich transmembrane 
protein 2 NS 0,4 0,45 0,6 0,58 
LIMCH1 NM_014988.1 LIM and calponin 
homology domains 
1 0,51 0,49 0,47 0,48 NS 
LRCH2 NM_020871.2 leucine-rich repeats 
and calponin 
homology (CH) 
domain containing 2 NS 1,3 NS NS 2,27 
MARVELD2 NM_144724.1 MARVEL domain 
containing 2 0,64 0,57 0,61 0,67 0,66 
MYH10 NM_005964.1 myosin, heavy chain 
10, non-muscle NS 0,51 0,55 0,68 0,63 
NDN NM_002487.2 necdin homolog 
(mouse) 0,75 0,57 NS NS NS 
PAFAH1B1 NM_000430.2 platelet-activating 
factor 
acetylhydrolase, 
isoform Ib, subunit 1 
(45kDa) NS 0,47 0,71 0,74 0,79 
PPAP2B NM_177414.1 phosphatidic acid 
phosphatase type 
2B 1,92 1,86 2,66 1,56 NS 
SPAG9 NM_172345.1 sperm associated 
antigen 9 1,51 2,19 2,22 NS NS 
TEK NM_000459.2 TEK tyrosine kinase, 
endothelial NS 0,53 NS NS NS 
    
     
  
GTPase activity  
     
  
  
      
  
ARHGAP20 NM_020809.2 Rho GTPase 
activating protein 
20 0,56 1,77 1,43 NS 2,01 
ARHGAP28 NM_030672.2 Rho GTPase 
activating protein 
28 NS 0,47 NS NS NS 
ARL1 NM_001177.3 ADP-ribosylation 
factor-like 1 NS 0,56 0,72 0,74 NS 
ARL4A NM_0010371 ADP-ribosylation 0,6 0,43 0,45 0,54 0,61 
78 
 
64.1 factor-like 4A 
FAM13B NM_0011018
00.1 
family with 
sequence similarity 
13, member B NS 0,51 0,62 0,67 NS 
RAB24 NM_0010316
77.1 
RAB24, member 
RAS oncogene 
family NS 1,6 NS NS 2,06 
RASIP1 NM_017805.2 Ras interacting 
protein 1 NS 0,71 NS NS 0,59 
RND1 NM_014470.2 Rho family GTPase 1 5,62 6,24 NS NS NS 
RND3 NM_005168.3 Rho family GTPase 3 NS 2,98 3,35 2,5 1,9 
RGL1 NM_015149.2 ral guanine 
nucleotide 
dissociation 
stimulator-like 1 NS NS NS NS 2,05 
TBC1D4 NM_014832.1 TBC1 domain family, 
member 4 NS 0,63 0,66 NS 0,53 
    
     
  
Intracellualr transport/endocytosis 
    
  
  
      
  
AP3M2 NM_006803
.2 
adaptor-related 
protein complex 3, 
mu 2 subunit 0,47 0,56 0,75 NS NS 
ANKFY1 NM_020740
.1 
ankyrin repeat and 
FYVE domain 
containing 1 NS 1,21 1,23 NS 2,16 
FNBP1L NM_017737
.3 
formin binding 
protein 1-like NS 0,57 NS NS NS 
MALL NM_005434
.3 
mal, T-cell 
differentiation 
protein-like NS NS 2,11 NS NS 
PEX11B NM_003846
.1 
peroxisomal 
biogenesis factor 11 
beta NS 0,48 0,6 0,67 NS 
SH3D19 NM_001009
555.2 
SH3 domain 
containing 19 0,68 0,54 0,57 0,68 0,69 
SIRPA NM_080792
.1 
Signal-Regulatory 
Protein Alpha 0,65 0,55 0,63 0,63 0,73 
STX11 NM_003764
.2 
syntaxin 11 
3,81 4,86 4,13 2,22 2,51 
VPS36 NM_016075
.2 
vacuolar protein 
sorting 36 homolog 
(S. cerevisiae) 0,68 0,5 0,66 0,72 NS 
VPS4B NM_004869
.2 
vacuolar protein 
sorting 4 homolog B 
(S. cerevisiae) NS 0,57 NS 0,81 NS 
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Vasculature development/tissue remodeling 
  
      
  
ADAMTS1 NM_006988
.3 
ADAM 
Metallopeptidase 
With 
Thrombospondin 
Type 1 Motif, 1 NS 5,21 9,92 3,2 NS 
ADAMTS9 NM_182920
.1 
ADAM 
metallopeptidase 
with thrombospondin 
type 1 motif, 9 NS NS 2,24 NS NS 
BAMBI NM_012342
.2 
hypothetical 
LOC729590; BMP and 
activin membrane-
bound inhibitor 
homolog (Xenopus 
laevis) NS 4,52 2,62 NS NS 
BMP6 NM_001718
.2 
bone morphogenetic 
protein 6 NS 0,53 0,67 NS NS 
EFNB2 NM_004093
.2 
ephrin-B2 
NS 0,49 NS NS NS 
FAP NM_004460
.2 
fibroblast activation 
protein, alpha NS 2,4 1,58 NS NS 
GPR180 NM_180989
.3 
G protein-coupled 
receptor 180 NS 1,41 NS 1,18 2,02 
ID1 NM_181353
.1 
inhibitor of DNA 
binding 1, dominant 
negative helix-loop-
helix protein 0,4 2,33 NS NS NS 
ID2 NM_002166
.4 
inhibitor of DNA 
binding 2, dominant 
negative helix-loop-
helix protein NS 2,37 1,67 NS NS 
KLHL12 NM_021633
.2 
kelch-like 12 
(Drosophila) NS 0,49 0,69 0,73 NS 
MAPK6 NM_002748
.2 
mitogen-activated 
protein kinase 6 1,26 0,54 0,62 0,76 0,74 
NRP1 NM_003873
.3 
neuropilin 1 
0,59 0,59 NS NS NS 
TGFBR3 NM_003243
.2 
transforming growth 
factor, beta receptor 
III 0,56 0,57 0,59 0,68 NS 
Table 7. The HUVEC expression of genes related to adhesion, cell motion and development upon infection with 
S. aureus blood isolates. The genes are divided in several subgroups in accordance to their specific function. 
Each gene symbol corresponds with the full gene name; “Gene Bank” accession number; and fold of 
transcriptional change for every S. aureus isolates and TNF-alpha treatment. The significantly upregulated 
genes are shown in red; the significantly downregulated genes in blue; and the not significantly expressed 
genes in grey. The data shown is the mean from three independent experiments. The p-values were 
determined respectively to differential expression of mock-treated control and detection p-values. The 
differential p-value: p≤0.05; ns= not significant. The detection p-value: p≤0.05; ns= not significant. 
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3.8.4.1. Strain-specific expression of structural and developmental genes 
Within the group of genes related to cytoskeletal/intracellular trafficking/vasculature 
development, the most differentially expressed transcripts observed are the strains 
K1801/10, 8325-4, and 6850. These strains have the strongest effects on endothelial barrier 
function, as indicated by TER decrease performed in previous studies (Kramko et al., 2013). 
However, the amount of upregulated genes in the group of strains affected TER was similar. 
For this reason, we assume that these genes might be involved in the structural organization 
and control of cell junctions, the cytoskeleton and small GTPase´s proteins relating to 
junctional integrity and endothelial barrier function regulation. Strain K70058396, which 
does not induce a TER decrease, showed the lowest changes in expression of the group by 
upregulating six and downregulating three transcripts.  
The data related to differentially expressed cytoskeletal genes can be of great help to 
better understand the regulation of endothelial permeability and bacteria translocation 
during staphylococcal infection. For example, RND1 is the gene encoding a protein that 
belongs to the Rho GTPase family. The RND1 is known to play a role in cortical actin 
inhibition (Nobes et al., 1998). This gene is upregulated by TNF-α and strain K1801/10 
treatments, making it a possible candidate participating in endothelial permeability 
regulation during S. aureus infection.  
In contrast to the upregulated genes, the downregulated transcripts display greater 
variability. In particular, 29 genes were down-regulated in HUVEC following infection with 
K1801/10, while only 3 of them corresponded to 8325-4 infected cells. However, the 
majority of these genes are also involved in various cell functions including tissue 
remodeling, vascular development and intracellular trafficking. For example, predominantly 
downregulated by strain 6850 and K1801/10, genes COL3A1 and MYH10 are induced by 
developmental stimuli or the BMP6 gene, which participates in tissue remodeling.  
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3.8.5. Differential expression of HUVEC transcription factors and signaling 
molecules  
Differentially expressed genes encoding transcription factors and signaling molecules are 
listed in the table 8 (Table 8). 
Gene 
symbol 
Gene bank 
accession 
number Full gene name 
Fold 
change 
TNF-α 
treated 
Fold 
change 
K1801/10 
Fold 
change 
6850 
Fold 
change 
K70058396 
Fold 
change 
8325-4 
  
Pos. 
Control S. aureus strains  
  
      
  
Transcription factors and signalling  
  
      
  
AIRE NM_000659.1 autoimmune 
regulator NS 2,33 NS NS NS 
ATF3 NM_0010302
87.1 
activating 
transcription 
factor 3 NS 14,46 7,62 NS NS 
BATF2 NM_138456.3 basic leucine 
zipper 
transcription 
factor, ATF-like 2 NS 5,26 3,87 1,78 8,26 
CEBPB NM_005194.2 CCAAT/enhancer 
binding protein 
(C/EBP), beta NS 2,28 1,76 NS NS 
CEBPD NM_005195.2 CCAAT/enhancer 
binding protein 
(C/EBP), delta 5,29 5,89 5,08 1,8 5,14 
CXCR7 NM_020311.1 chemokine (C-X-C 
motif) receptor 7 9,1 3,19 2,84 2,2 NS 
DDX58 NM_014314.2 DEAD (Asp-Glu-
Ala-Asp) box 
polypeptide 58 2,17 7,58 7,31 2,78 15,23 
DDX60 NM_017631.3 DEAD (Asp-Glu-
Ala-Asp) box 
polypeptide 60 1,48 2,97 2,33 1,41 6,17 
DACH1 NM_080759.3 dachshund 
homolog 1 
(Drosophila) 0,41 0,55 NS NS NS 
DKK1 NM_012242.2 dickkopf homolog 
1 (Xenopus laevis) NS NS 3,38 3,3 NS 
DLL1 NM_005618.2 delta-like 1 
(Drosophila) NS 1,78 NS NS 2,79 
EGR1 NM_001964.2 early growth 
response 1 NS 4,02 2,39 NS NS 
EGR2 NM_000399.2 early growth NS 3,71 2,89 1,59 1,59 
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response 2 
ELF1 NM_172373.2 E74-like factor 1 
(ets domain 
transcription 
factor) NS 1,86 2,27 NS 2,38 
ELF4 NM_001421.1 E74-like factor 4 
(ets domain 
transcription 
factor) NS 2,11 NS 1,3 NS 
FOS NM_005252.2 v-fos FBJ murine 
osteosarcoma viral 
oncogene 
homolog NS 17,22 7,07 NS NS 
FOSB NM_006732.1 FBJ murine 
osteosarcoma viral 
oncogene 
homolog B NS 30,41 25,84 11,2 NS 
FOXO1 NM_002015.2 forkhead box O1 NS 0,59 NS NS NS 
HOXA9 NM_152739.2 homeobox A9 0,49 0,47 NS NS NS 
HNRNPA0 NM_006805.3 heterogeneous 
nuclear 
ribonucleoprotein 
A0 NS 0,49 NS NS NS 
JUN NM_002228.3 jun oncogene NS 5,82 3 2,76 NS 
JUNB NM_002229.2 Jun B Proto-
Oncogene 1,66 3,67 1,79 NS 1,48 
IER3 NM_052815.1 immediate early 
response 3 NS NS 0,53 NS 0,6 
IRAK2 NM_001570.3 interleukin-1 
receptor-
associated kinase 
2 5,71 3,47 2,64 1,9 NS 
IRF1 NM_002198.1 interferon 
regulatory factor 1 7,82 8,17 7,02 2,99 9,49 
IRF7 NM_004029.2 interferon 
regulatory factor 7 1,37 6,95 4,17 2,42 7,81 
IRF9 NM_006084.3 interferon 
regulatory factor 9 1,28 2,04 2,25 1,71 3,41 
JAK2 NM_004972.2 Janus kinase 2 1,17 1,64 1,61 NS 2,86 
KLF2 NM_016270.2 Kruppel-like factor 
2 (lung) NS 2,39 2,07 NS NS 
KLF4 NM_004235.3 Kruppel-like factor 
4 (gut) NS 15,98 8,7 NS NS 
MAP3K8 NM_005204.2 mitogen-activated 
protein kinase 
kinase kinase 8 1,82 3,1 2 1,14 NS 
MYD88 NM_002468.2 myeloid 
differentiation 
primary response 
gene (88) NS 1,96 1,88 1,33 3,27 
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NFKBIA NM_020529.1 nuclear factor of 
kappa light 
polypeptide gene 
enhancer in B-cells 
inhibitor, alpha 8,59 5,2 3,56 2,48 NS 
NFKBIZ NM_0010054
74.1 
nuclear factor of 
kappa light 
polypeptide gene 
enhancer in B-cells 
inhibitor, zeta 2,48 6,61 5,03 1,82 NS 
RIPK2 NM_003821.4 receptor-
interacting serine-
threonine kinase 2 13,7 7,89 6,22 2,18 NS 
SOCS1 NM_003745.1 suppressor of 
cytokine signaling 
1 NS 2,19 1,78 1,34 3,02 
SOCS3 NM_003955.3 suppressor of 
cytokine signaling 
3 NS 2,41 1,68 NS 1,55 
STAT1 NM_139266.1 signal transducer 
and activator of 
transcription 1, 
91kDa 0,56 1,53 1,4 NS 3,31 
STAT2 NM_005419.2 signal transducer 
and activator of 
transcription 2, 
113kDa NS 1,82 1,81 NS 4,61 
TNFRSF12A NM_016639.1 tumor necrosis 
factor receptor 
superfamily, 
member 12A NS 1,82 NS 2,17 NS 
TNFAIP3 NM_006290.2 tumor necrosis 
factor, alpha-
induced protein 3 16,46 11,49 5,15 NS NS 
TNFSF13B NM_006573.3 tumor necrosis 
factor (ligand) 
superfamily, 
member 13b NS 2,38 2,26 NS 8,02 
TRAFD1 NM_006700.1 TRAF-type zinc 
finger domain 
containing 1 1,42 1,71 1,52 NS 3,34 
TRIB1 NM_025195.2 tribbles homolog 1 
(Drosophila) 2,21 4,45 3,69 2,37 2,11 
TNFRSF1B NM_001066.2 tumor necrosis 
factor receptor 
superfamily, 
member 1B 0,42 0,47 0,51 NS NS 
TSC22D2 NM_014779.2 TSC22 Domain 
Family, Member 2 NS 2,44 1,89 1,56 NS 
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UNC93B1 NM_030930.2 unc-93 homolog 
B1 (C. elegans); 
unc-93 homolog 
B6 (C. elegans); 
unc-93 homolog 
B3 pseudogene (C. 
elegans); similar to 
unc-93 homolog 
B1 (C. elegans) NS 1,35 1,25 NS 2,05 
ZC3HAV1 NM_024625.3 zinc finger CCCH-
type, antiviral 1 1,27 5,49 5,48 2,22 5,37 
ZFP36 NM_003407.1 zinc finger protein 
36, C3H type, 
homolog (mouse) 3,01 11,91 4,61 NS NS 
ZFYVE26 NM_015346.2 zinc finger, FYVE 
domain containing 
26 NS NS NS NS 2,1 
Table 8. The HUVEC expression of transcription factors and signaling regulators upon infection with S. aureus 
blood isolates. The genes are divided in several subgroups in accordance to their specific functions. Each gene 
symbol corresponds with the full gene name; “Gene Bank” accession number; and fold of transcriptional 
change for every S. aureus isolates and TNF-alpha treatment. The significantly upregulated genes are shown in 
red; the significantly downregulated genes in blue; and the not significantly expressed genes in grey. The data 
shown is the mean from three independent experiments. The p-values were determined respectively to 
differential expression of mock-treated control and detection p-values. The differential p-value: p≤0.05; ns= 
not significant. The detection p-value: p≤0.05; ns= not significant. 
 
The specific mechanical background of strain-specific induction with differential 
expression as well as the role of particular transcripts still requires further investigation. For 
example, transcriptional factors JUN, JUNB and FOS, which are predominantly differentially 
expressed upon infection with cytotoxic strains, where shown to play a role in a variety of 
cellular mechanisms including cell survival (Kriehuber et al., 2005). Therefore, a functional 
study is required to elucidate the exact mechanisms playing role  during S. aureus infection. 
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3.9. S. aureus strain-related induction of genes involved in 
endothelial cell death  
3.9.1. Cytotoxic strains of S. aureus induces cell death-related gene 
expression in endothelial cells  
Based on the microarray results, we chose to focus on a group of cell death-related genes 
to study S. aureus-induced endothelial apoptosis in greater detail. To that end, with respect 
to S. aureus-induced cytotoxicity, we analyzed genes that were differentially regulated upon 
endothelial infection with the four selected strains: 6850, K1801/10, K70058396 and 8325-4. 
Considering many different cell death mechanisms such as necrosis, apoptosis, necroptosis 
etc. to avoid bias (Yipp and Kubes, 2013), we divided the cell death-related genes into two 
groups. One group contained genes involved in cell death induction (Table 9) while the 
second group contained cell death prevention (Table 10). Treatment of endothelium with 
TNF-alpha served as the positive control for inflammation just as before as well as an 
extrinsic inductor of the apoptotic pathway through the TNF-R1 receptor (Beg and 
Baltimore, 1996).     
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Table 9. HUVEC´ transcripts related to cell death by four S. aureus isolates and TNF-alpha. The data shows the 
mean from three independent experiments. The p-values related to respectively differential expressions of 
mock-treated control and detection p-values. The differential p-value: p≤0.05, ns= not significant. The 
detection p-value: p≤0.05, ns=not significant. Cytotoxic strain relative gene expression = gene FC (cytotoxic 
strain)/gene FC (non-cytotoxic strain). Non-cytotoxic strain relative gene expression = gene FC (non-cytotoxic 
strain)/gene FC (cytotoxic strain). 
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Table 10. HUVEC´ transcripts related to cell death prevention by four S. aureus isolates and TNF-alpha. The 
data shows the mean from three independent experiments. The p-values related to respectively differential 
expressions of mock-treated control and detection p-values. The differential p-value: p≤0.05, ns= not 
significant. The detection p-value: p≤0.05, ns=not significant. Cytotoxic strain relative gene expression = gene 
FC (cytotoxic strain)/gene FC (non-cytotoxic strain). Non-cytotoxic strain relative gene expression = gene FC 
(non-cytotoxic strain)/gene FC (cytotoxic strain). 
 
The gene order was defined by the ratio between the FC of the cytotoxic strain K1801/10 
to the FC of the non-cytotoxic strain 8325-4. This ratio was named, “cytotoxic strain relative 
gene expression”. The highest relative gene expression of cytotoxic strain K1801/10 
corresponds to the highest FC of this strain while the lowest relative gene expression of 
K1801/10 corresponds to the highest FC of the non-cytotoxic strain 8325-4. The cytotoxic 
strain relative gene expression decreases from the top to the bottom of the table  (see 
legend Table 9, 10).  
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For a better visualization of the strain-specific transcriptions of cell death-related genes 
(Table 9, 10), we generated a “filled radar chart” (Fig. 34, 35). The cytotoxic S. aureus strains 
K1801/10, 6850 and K70058396 showed distinctive expression patterns of genes related to 
cell death induction (Fig. 30) and prevention (Fig. 31). The expression patterns of the non-
cytotoxic strain 8325-4, for both gene groups, differed from the ones induced by cytotoxic 
strains (Fig. 30, 31). 
 
Figure 30. HUVEC´ gene expression of transcripts related to cell death prevention by four S. aureus isolates and 
TNF-alpha represented in filled radar chart. Numbers represent gene fold change. 
 
The gene expression of transcripts in treatment with the cytotoxic strain K70058396 was 
generally lower than for the other isolates. However, relative gene expression of K70058396 
had similar traits when compared with other cytotoxic isolates. Relative gene expression for 
transcription factors and apoptosis regulators such as JUN, RIPK2, PHLDA1 (Table 11, 12) 
was higher for all cytotoxic strains compared to the non-cytotoxic strain 8325-4 (Fig. 30). 
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Figure 31. HUVEC´ gene expression of transcripts related to cell death prevention by four S. aureus isolates and 
TNF-alpha represented in filled radar chart. Numbers represent gene fold change. 
 
Considering the strain-specific differences in differentially regulated HUVEC cell death 
genes, we assume that different transcription factors might be involved in their 
transcription. 
 
3.9.2. Different transcription factors involved in S. aureus-induced cell death 
gene expression  
We further investigated transcription factors that might control cell death-related gene 
expression upon S. aureus infection. The results are listed below and correspond to the 
enrichment score of the genes´ overrepresented binding sites for particular transcription 
factors (TFs) (by Pscan Software (Zambelli et al., 2009)). Promoter region analysis of 
signaling pathways indicated a high enrichment score for TFs involved in interferon 
signaling, such as NF-κB and PI-3K signaling (Table 11).  
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Table 11. Promoter region analysis of HUVEC´ genes related to cell death by Pscan. The different colors 
correspond to the analysis of different gene sets of the HUVEC treatments. For each treatment, a list of 
enriched transcription factors and their respective p-value is presented. The p-values of the enrichment scores 
ranking relate to the compared probability of matrix set used in the analysis to set of genes taken by chance.   
 
To begin, the promoter region analysis demonstrated a high significance for TF CREB1 for 
all cytotoxic S. aureus strains. Furthermore, TFs NFKB1, REL and RELA involved in NF-kB 
pathway were also involved in the regulation of cell death-related gene expression by 
cytotoxic strains, but were much less significant. Finally, the promoter region analysis for 
the non-cytotoxic strain 8325-4 showed a high significance for interferon signaling TFs. 
Particularly, these included STAT1, STAT1::STAT2 and IRF1 while TFs CREB1 and NFKB1 
corresponding to NF-kB and PI-3K pathways were completely absent.  The promoter region 
analysis for the TNF-alpha treatment showed the highest significance for the TFs of the NF-
kB pathway. TF CREB1 was also significantly enriched, but less so than for cytotoxic S. aureus 
isolates (Table 11). 
Based on this data, we hypothesize that cytotoxic S. aureus strains modulate cell death-
related gene expression in HUVEC via TF of PI-3K cascade, namely CREB1. Apoptotic gene 
expression induced by cytotoxic isolates partly overlaps with TNF-alpha-induced cell death 
transcript expression, likely through TFs of the NF-kB signaling pathway. However, it seems 
that the non-cytotoxic strain of S. aureus affects cell death gene expression through the 
interferon signaling pathway, which may not participate in S. aureus-induced endothelial 
cell death. 
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3.10. Influence of kinase signaling on the survival of endothelium 
upon S. aureus infection  
The downstream transcription factors NF-kB and CREB1 require additional activation by 
MAPKs (Wen et al., 2010). In turn, the signaling kinases p38, ASK1 (Yang et al., 2008), JNK 
and ERK ½ (Yang et al., 2000) were also shown to contribute to cell death regulation in S. 
aureus infected endothelium (Esen et al., 2001).  The function of PKC and PI3K kinases was 
reported to regulate the activation of respective mitogen-activated protein kinases (MAPKs) 
which thereby implies a possible role in cell death regulation. 
The differential expressions of JUN, JUNB, BCL3 and FOS genes induced by cytotoxic 
isolates partly proves the involvement of MAPKs during the infection process. Transcription 
of these genes was shown to depend on AP-1 and/or c-JUN transcription factors activated 
by MAPKs (Kappelmann et al., 2014). 
 
3.10.1. Inhibition of protein kinases affects HUVEC survival upon S. aureus 
infection  
Based on bioinformatic analyses of cell death gene expressions and the data concerning 
their transcription regulators, we attempted to verify the role of HUVEC protein kinases in 
promoting endothelial cell death under apoptotic stimuli. 
To investigate the role of a particular kinase in S. aureus-induced endothelial cell death in 
greater detail, we applied specific inhibitors of six protein kinases prior to HUVEC infection 
or H₂O₂ application. The name of the respective inhibitor and particular time of pre-
incubation are listed below (Table 12).  
 
Inhibitor Working 
concentration 
Time of 
pre-
incubation 
in hours 
Mode of action References 
NQDI-1 25 µM in DMSO 
 
3 Selective inhibitor of 
apoptosis signal-regulating 
kinase 1 (ASK1, MAP3K5). 
Prevents apoptosis via 
inhibition of caspase-3  
activation  
(Volynets et 
al., 2011; 
Song et al., 
2014) 
SB203580 10 µM in DMSO 1 Pyridinyl imidazole 
inhibitor of p38 mitogen-
(Cuenda et 
al., 1995) 
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activated protein (MAP) 
kinase 
PD98059 10 µM in DMSO 1 PD98059 is a potent and 
selective inhibitor of 
ERK1/2 (p44/p42 MAPK) 
by MEK1/2. 
(Alessi et al., 
1995) 
Wortmannin 1 µM in DMSO 
 
0,5 Cell-permeable, selective 
and irreversible inhibitor 
of phosphatidylinositol 3-
kinase (PI3K) 
(Fukao and 
Koyasu, 2003) 
Bisindolylmaleimide 
I 
5 µM in DMSO 
 
1 Highly selective, cell-
permeable, and reversible 
protein kinase C (PKC) 
inhibitor. 
(Toullec et 
al., 1991) 
SP600125 25 µM in DMSO 
 
0,5 Cell-permeable, selective 
and reversible inhibitor of 
c-Jun N-terminal kinase 
(Bennett et 
al., 2001) 
Table 12. MAPK kinases inhibitors.  
 
After pre-treatment with respective kinase inhibitors (Table 14), HUVEC were infected 
with the selected S. aureus strains according the standard protocol (Fig. 32) with the notable 
addition of inhibitors. 
 
 
Figure 32. The scheme of MAPK kinases inhibition assay. 
 
The application of ASK-1 and p38 MAPK kinases inhibitors (NQDI-1 and SB203580) were 
able to rescue endothelial cells from the apoptotic stimuli of hydrogen peroxide as well as 
the three pro-apoptotic strains of S. aureus K1801/10, 6850 and K70058396. In all cytotoxic 
strains and H₂O₂ treated cells, we observed fewer apoptotic events, decreased gap 
formation and the maintenance of a partially intact HUVEC monolayer.  Endothelial cell 
death was not observed in mock treatments with or without inhibitors and there were no 
discernible differences for strain 8325-4 (Fig. 33, 34). The treatments with either ASK-1 or 
p38 MAPK kinase inhibitors demonstrated similar effects.  The similar results of ASK1 and 
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p38 inhibition on endothelial survival can be explained by the same mechanism, since ASK1 
is an upstream activator of p38 MAPK. The observed effect implies that these kinases play a 
role in cell death signaling under various apoptotic stimuli including cytotoxic S. aureus 
infection. 
ASK 1 inhibitor 
 
Figure 33. HUVEC infected with K70058396 and K1801/10 S. aureus strains with and without ASK1 inhibitor 
compared to the mock control and H₂O₂ treatments at 24 hours post-infection (20x). 
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p38 inhibitor 
 
Figure 34. HUVEC infected with K70058396 and K1801/10 S. aureus strains with and without p38 inhibitor 
compared to the mock control and H₂O₂ treatments at 24 hours post-infection (20x). 
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ERK ½ inhibitor 
During inhibition of ERK ½ MAPK kinase (PD 98059), we saw a decrease in endothelial cell 
death and diminished gap formation with H₂O₂ and cytotoxic strains K1801/10 and 6850. 
The strain K70058396  induced the same level of endothelial cell death with or without ERK 
½ inhibitor. Controls receiving mock treatments and strain 8325-4 did not demonstrate any 
changes (Fig. 35).  
Figure 35. HUVEC infected with K70058396 and K1801/10 S. aureus strains with and without ERK1/2 inhibitor 
compared to the mock and H₂O₂ treatments at 24 hours post-infection (20x). 
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PKC inhibitor 
In comparison to the ERK ½ inhibitor, it seems that PKC kinase has a pro-survival effect on 
endothelial cells as its inhibition lead to an increase of HUVEC cell death upon apoptotic 
stimuli. When PKC inhibitor (Bisindolylmaleimide I) was applied, exposure to hydrogen 
peroxide and cytotoxic S. aureus strains caused greater endothelial cell death (Fig. 36). 
Controls receiving mock treatments and strain 8325-4 showed no differences in induced cell 
death. 
 
Figure 36. HUVEC infected with K70058396 and K1801/10 S. aureus strains with and without PKC inhibitor 
compared to the mock control and H₂O₂ treatments at 24 hours post-infection (20x). 
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PI3K inhibitor 
The application of PI3K inhibitor (Wortmannin) resulted in a loss of cells from the 
substrate (Fig. 37) with any level of treatment. Furthermore, applications of both H₂O₂ and 
PI3K inhibitor further decreased the number of surviving cells when compared with H₂O₂ 
alone. The infection of the cells with S. aureus strains had no visible effect on cell survival 
and did not induce cell death. This finding demonstrates that PI3K is required for viability 
and maintenance of an intact cell monolayer (Fig. 37). 
 
Figure 37. HUVEC infected with K70058396 and K1801/10 S. aureus strains with and without PI3K inhibitor 
compared to the mock control and H₂O₂ treatments at 24 hours post-infection (20x). 
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JNK inhibitor 
When exposed to JNK kinase inhibition, endothelial cells started to die shortly after 
pretreatment with the SP600125 inhibitor. The JNK kinase inhibition seems to have an 
absolutely lethal effect on endothelium and it’s effects did not differ for any of the 
treatments after 24 hours following infection (Fig. 38). 
 
Figure 38. HUVEC infected with K70058396 and K1801/10 S. aureus strains with and without JNK inhibitor 
compared to the mock control and H₂O₂ treatments at 24 hours post-infection (20x). 
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The study suggests a possible involvement of regulatory kinases in S. aureus-induced 
endothelial cell death. Our results suggest that phosphorylated ASK-1, p38, and possibly ERK 
½ kinases can transduce apoptotic signals causing S. aureus-induced endothelium cell death 
after the endothelium has been infected with cytotoxic strains. On the other hand, we 
assume that phosphorylated PKC kinase is important for endothelium survival upon 
induction with a pro-apoptotic stimuli. Kinases PI3K and especially JNK appear to be 
absolutely necessary under normal homeostatic endothelial conditions as their inhibition 
was shown to lead to cell death induction without any cytotoxic agents. The possible 
mechanisms involved in these observed effects will be addressed in further detail in the 
discussion. 
  
100 
 
4. Discussion 
Staphylococcus aureus is member of the family Staphylococcaceae and a facultative 
anaerobic, gram-positive bacterium that can be found in about 50% of the human 
population on the skin and within the upper parts of the respiratory tract (Wertheim et al., 
2005). However, S. aureus can cause diverse infections ranging from simple skin boils via 
abscesses up to sepsis and the development of septic shock (Archer, 1998). The specific 
development of these diverse infections depends both on the immune status of the host 
and virulence of the given strain. S. aureus virulence is a subject of high variability and 
genetic plasticity that are also thought to be the main contributor to disease variability. 
However, an evident relationship between particular strains, their virulence factors and 
observed pathophysiological behavior is not always clear (Foster et al., 2014). Treatment of 
S. aureus infections is complicated with the occurrence of antibiotic resistance, often to 
multiple antibiotics. This problem is of particular significance in combination with severe 
diseases such as endocarditis, osteomyelitis, sepsis and septic shock, as the lethality with 
these complicating circumstances, irrespective to full scale intensive care treatment, still 
ranges between 32% to 58% (Romero-Vivas et al., 1995; Cosgrove et al., 2003). 
The development of severe diseases which mostly arise from local infections is usually 
associated with bacteremia, where host pathogen encounter occurs in the vasculature 
(Hickey and Kubes, 2009). Once in the blood, the majority of the bacteria are cleared by 
professional phagocytes (Gresham et al., 2000), but the vascular endothelium has also been 
shown to be infected (Weidenmaier et al., 2005). This phenomenon might be of significant 
relevance in the development of sepsis and septic shock with the formation of septic 
metastases since the bacteria need to overcome the endothelial cell layer. In this way, 
infection by S. aureus and transmigration of the pathogen through the endothelial cell layer 
might be one of the key steps in sepsis and septic shock development. 
However, despite the it’s clear importance, the wide variability of S. aureus strains, its 
virulence factors and varying pathophysiological behavior mean that current research has 
yet to see the development of a clear concept describing the interrelationship between 
disease development and strain specificity. 
In this study, we tested 24 strains and identified which showed extreme 
pathophysiological behavior in endothelial cells with respect to pro-inflammatory and anti-
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inflammatory reactivity. The majority of the tested strains caused a mixture of pro- and anti-
inflammatory responses in endothelium, which is consistent with the diversity of related 
disease development (Fig. 39). However, several of the tested strains displayed clear anti-
inflammatory behavior along with the allowance of bacterial transmigration as well as the 
blockage of a TNF-α induced activation. Other strains caused a pro-inflammatory phenotype 
that, in contrast, did not allow for bacterial transmigration. With this knowledge, we used 
isolated strains as tools in order to uncover the fundamental mechanisms and signaling 
pathways in endothelium and better understand the diversity of S. aureus infections. Here, 
we performed a genome wide RNA array analyses following the infection of endothelial cells 
with the chosen strains. We quickly identified different mechanisms and signaling pathways 
controlling S. aureus-induced apoptosis, intracellular bacterial survival and inflammatory 
versus anti-inflammatory reactivity. 
 
 
Figure 39. The proposed scheme of the host response to different S. aureus isolates.  
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Clarifying the mechanism behind the ability of some S. aureus strains to down-regulate 
immune response can be of a significant clinical importance. It is more than likely that, in 
some cases, complications during S. aureus infection could be related to modulation of the 
immune system reactivity. This criterion needs to be confirmed in animal models or in vivo 
and can be used for evaluating alternative medical interventions. 
 
4.1. HUVEC expression study and microarray data analysis 
To study the strain-specific endothelial response to S. aureus infection at a the level of 
gene expression, we performed a microarray assay due to its reputation as a broadly used 
method to investigate changes in cellular gene transcription caused by vast number of 
stimuli. In our research, we aimed to investigate early transcriptional changes of 
endothelium infected by six different S. aureus strains differing in their infectious properties 
as discussed in the results. To accomplish this, we extracted total endothelial mRNA and 
reverse transcribed as well as labelled target mRNA through several washing steps. The final 
step of the experiment included the loading of nucleic acid on a beadchip, hybridization of 
the transcripts with oligonucleotides on the beadchip surface and detection of fluorescent 
signal. This technique has the advantage of being high speed, highly specific and allows 
screening biological replicates. The disadvantages of this experimental design include 
affordability and rather low flexibility. The oligonucleotide array requires expensive 
specialized equipment and beadchips are costly. Furthermore, the complexity of beadchip 
production causes it to be a product restricted to centralized manufacturing facilities 
thereby limiting its flexible usage (Facility, 2015). 
The raw data of the microarray was analyzed using specialized software (Genome Studio) 
which provided the normalized data of differential expression fold change and significance 
for each gene of each sample when compared to the untreated control. Further 
bioinformatical analyses offer additional features to perform functional group clustering, 
gene ontology analysis, promoter region analysis etc. These methods are widely used to 
work with large transcriptional datasets obtained during microarray. The basic principle of 
any of these bioinformatical analyses is to decrease the rate of data variability and group it 
in accordance to its functional similarity, by attribution to a same process or regulatory 
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pathway. During the microarray analyses, we used DAVID and PScan online software to 
predict possible induction mechanisms of endothelial response upon strain-specific 
infection. 
The DAVID software analyzes sets of transcriptome data, grouping the genes and finally 
predicting their possible involvement in shared pathways or functions. PScan software 
provides predictions of transcription factors that may be involved in the transcriptional 
regulation of genes of a particular uploaded set.  DAVID and PScan prediction is based on 
the same principle of calculating enrichment scores for the data of interest. These scores are 
generated using data from a number of sources and databases and the result reflects 
whether a particular user gene list is associated (enriched) with a particular signaling 
pathway compared to the sets of genes taken by random chance.   
It is important to understand that outcomes of bioinformatics analyses give a hint as to  
which processes may be involved in an observed phenomenon, but this does not qualify as a 
legitimate discovery. For this reason, each conclusion based solely on bioinformatic analyses 
should be confirmed on a functional level. 
Before beginning with sophisticated analytical approaches it is important to do an initial 
data grouping of a transcriptional dataset. For example, the expression activation of “basic” 
immune response includes a set of endothelium genes that are differentially expressed 
during infection with any of the tested S. aureus strains. The differential expression of these 
genes is induced by non-specific S. aureus pathogen associated molecular patterns (PAMPs). 
The strain-specific S. aureus virulence factors, determinants and metabolites can cause 
specific differential gene expression corresponding to infection with a single, particular 
strain or a group of strains (Table 13).    
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S. aureus strains 
Gene symbol K1801/10 6850 K70058396 8325-4 
 
Non-specific response (fold change) 
CCL2 9,87 7,97 6,79 7,33 
CX3CL1 25,29 23,4 5,62 21,97 
CXCL10 84,8 64,62 12,32 107,3 
TAP1 6,97 6,2 2,93 11,59 
AXUD1 7,48 3,4 2,45 2,52 
 
Group-specific response (fold change) 
ATF3 14,46 7,62 NS NS 
IL-10 3,85 2,69 NS NS 
CD83 3,7 3,35 NS NS 
SERPINE1 3,19 2,62 NS NS 
BIRC3 6 4,33 NS NS 
 
Strain-specifically expressed genes (fold change) 
HES1 2,29 NS NS NS 
MALL NS 2,11 NS NS 
CLDN11 NS NS 2,28 NS 
CLDN23 NS NS NS 3,13 
CASP1 NS NS NS 3 
Table 13. The example of gene expression group comparison.  
The qualitative analysis indicates the principle differences and possible mechanisms of 
gene expression induction. The quantitative analysis reflects overall differences in level of 
gene expression changes during the host-pathogen interaction, which can reflect stimuli 
intensity or possible active immunomodulation during infection.  
The analysis of differentially expressed genes during all treatments brought us to the 
conclusion that gene expression of non-specific transcripts induced by all S. aureus strains is 
likely induced by the same type of stimulus. This stimulus leads to a non-specific response 
that can be triggered by characteristic antigen determinants presenting in all S. aureus 
isolates. For example, cell wall peptidoglycan and lipoteichoic acid, muramyl di-peptide and 
bacterial RNA/DNA are well-known activators of transcription factors NF-kB and STAT1 via 
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cellular pattern recognition receptors (PRRs) (Loos et al., 2006).  Indeed, all S. aureus 
isolates that were used in our study were able to induce upregulation of chemokines 
CX3CL1, CXCL10 and CCL2, whose expression is known to be regulated by activated 
transcription factors NF-kB and STAT1 (Isozaki et al., 2008) (Table 13).  
It seems that the fold of expression change in the group of non-specifically expressed 
transcripts correlates with the level of endothelial receptor induction. It was shown that S. 
aureus strain-specific expression of bacterial capsules can mask surface peptidoglycan and, 
therefore, prevent phagocytosis (Wilkinson et al., 1979)  and likely lower NF-kB signaling via 
TLR 2 (Luong and Lee, 2002). Similarly, prevention of pathogen-induced phagolysosome 
fusion (Lam et al., 2010) or bacteria resistance to acidification in lysosomes (Lam et al., 
2010) can be prerequisite for a low activation of NOD 2 or RIG-I intracellular receptors.  
The strain-specific expression of strain-specific genes or group-specific genes 
demonstrated qualitative differences. We assume that differentially expressed endothelial 
genes that respond only to infection with particular isolate can point out principal 
differences in infection strategies between S. aureus strains. We hypothesize that the 
expression of strain-specific S. aureus virulence determinants is the reason for distinctive 
endothelial expression profiles and partly explains the broad variations in S. aureus infection 
scenarios.  
 
4.2. HUVEC infected with the Staphylococcus aureus isolates 
demonstrate strain-specific gene expression response 
During infection, pathogens are able to modulate host gene expression. The endothelium 
attempts to detect potential invaders and “switch on” defense mechanisms, which allow for 
a prevention of pathogen survival and dissemination. To remove dead or infected cells, host 
cells are release a number of cytokines and chemokines which attract professional immune 
cells to the site of inflammation. The pathogen can modulate host gene expression response 
by masking its location or inducing apoptosis to eliminate immune cells responsible for 
combatting infection. 
Endothelial cells actively participate in the host immune response. Aside from their 
important role in inflammation and signaling to specialized immune cells, they also regulate 
barrier function and thus provide an obstacle to spreading pathogens. All these functions 
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are closely connected to endothelium gene expression response upon infection with S. 
aureus.  
In this study, we identified early endothelial strain-specific expressions of HUVEC infected 
with six S. aureus strains and the pro-inflammatory response of HUVEC treated with TNF-α.  
The microarray results largely confirmed previous reports, which demonstrated a highly 
diverse endothelial expression response to different S. aureus strains (Grundmeier et al., 
2010; Stark et al., 2009; Matussek et al., 2005). Based on strain-related endothelium 
expression, we attempted to elucidate particular differences in endothelium gene 
expression and the possible mechanisms involved in their regulation. The first important 
observation confirmed a highly heterogeneous differential expression of HUVEC upon 
strain-specific infection. The number of differentially regulated genes varied from 610 
transcripts affected by pro-inflammatory K1801/10 to only 98 transcripts by affected by 
anti-inflammatory K70058396. 
The second significant observation was that two pro-inflammatory strains appeared to 
induce the highest differential expression of genes involved in innate immune response, as 
in the number of transcripts and level of gene expression fold change. 
We believe that large variations in strain-related endothelial expression can be explained 
by a selection of S. aureus strains with different infectious properties, which simultaneously 
reflect the differences in bacterial virulence factor expression. Moreover, previous studies 
have suggested that important parameters influencing cellular response to S. aureus 
infection are determined by: S. aureus ability for successful adhesion and invasion and 
aggressiveness, including cytotoxicity and intracellular survival (Haslinger-Loffler et al., 
2005). Additionally, it has been reported that cellular response is linked to inflammatory and 
cytotoxic properties of S. aureus antigens such as LTA, PNG and TSST-1 (Mattsson et al., 
2008).  
Interestingly, we found that strains expressing high quantities of virulence regulators, 
toxins and adhesins, induced fewer changes in gene expression in endothelial cells while 
strains expressing low quantities of virulence factors, in comparison, provoked many more 
changes in gene expression in the endothelium. This intriguing data indicates that the 
virulence factors actively control gene expression in infected endothelium. These findings 
also support an earlier observation describing how S. aureus strains expressing many 
virulence factors are either highly invasive or aggressive (Iwatsuki et al., 2006).  
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For example, anti-inflammatory strain K70058396 with highly expressed virulence factors 
appeared to induce a weak endothelial expression response in compare with the other 
three isolates. It seems that a high expression of virulence factors by particular S. aureus 
strain can actively silence endothelial response and benefit bacteria by avoiding immune 
defense, thereby improving survival. However, we observed other strategies in avoiding 
endothelial response such as expressing a low amount of virulence factors, as demonstrated 
by strains K2900/10 and K9657/04.  
As such, we speculate that the isolates expressing the highest amounts of toxins are 
more prominent in intracellular survival and are likely able to multiply intracellularly. This 
hypothesis was supported and accepted as three S. aureus strains showing the highest 
production of virulence factors appeared to survive and grow intracellularly. Remarkably, 
the anti-inflammatory strain K70058396, with the highest production of virulence factors, 
had the highest rate of intracellular growth. It seems, however, that endothelial pro-
inflammatory activation can diminish this ability as one pro-inflammatory strain did not 
demonstrate intracellular growth and the second had a low rate of intracellular 
multiplication when compared with anti-inflammatory strain K70058396. 
Due to the logical consequences of high bacteria virulence of the multiplying strains, one 
could suggest stronger cytotoxic properties of such isolates. Indeed, three S. aureus strains 
that were able to survive and grow intracellularly induced apoptosis, which was 
demonstrated by Annexin/PI and caspase-3 assay. 
To study strain-specific mechanisms of cell death regulation in infected endothelium, we 
first analyzed a subset of endothelial differentially-regulated genes related to cell death. The 
transcriptional data gave us a hint as to which transcriptional factors and pathways could 
play a role in the differential expression of endothelial genes related to cell death.  
We found that infected endothelium showed a high variation of apoptotic gene 
expression upon strain-specific S. aureus infection. However, the main outcome of apoptotic 
gene expression analysis showed differences in subsets of up/down pro- and anti-apoptotic 
genes induced by cytotoxic and non-cytotoxic S. aureus isolates.  
We could thereby conclude that the differential expression of cell death genes related to 
strain-specific activation of transcription is mediated by specific virulence factors. 
Furthermore, we proposed that particular virulence factors could induce gene expression 
via defined endothelial transcription factors. This was suggested by the fact that cytotoxic 
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strains likely up/down-regulate gene expression via CREB1 and NF-kB transcription factors. 
In contrast, the non-cytotoxic strain 8325-4 induces cell death-related genes via 
transcription factors IRF1 and STAT1 belonging to the interferon signaling pathway (Fig. 40). 
Interestingly, the separate activation of NF-kB and interferon signaling pathways requires 
the involvement of different receptors which implies that pro-apoptotic stimuli have a 
connection with the NF-kB signaling pathway.  
 
Figure 40. Proposed model based on microarray data analyses. Depending on the cytotoxicity, S. aureus strains 
induce gene expression via the activation of different transcription factors.  
 
4.3. Strain-specific mechanisms of HUVEC cell death induction  
Based on transcriptional data analyses, we hypothesize that there are key differences in 
the ability to induce cell death between the different S. aureus isolates. It has been 
previously described that apoptosis is mediated through extrinsic or intrinsic pathways 
(Dhanasekaran and Reddy, 2008). Based on our research data, we propose that cytotoxic 
strains kill infected endothelial cells by induction of both extrinsic and intrinsic pathways. 
We propose that the extrinsic death receptor pathway is most likely activated by TLR 2 
and/or tumor necrosis factor receptor 1 accompanied by the activation of apoptosis-
inducing ligand receptor (TRAIL-R). The extrinsic death receptor pathway was shown to 
induce gene expression through NF-kB and CREB1 transcription factors (Hadad et al., 2011). 
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Additionally, this conclusion is supported by the differential expression of TNFAIP3, 
RIPK2, and BIRC3 genes that are upregulated by cytotoxic strains and by TNF-α treatment. 
The expression of these genes is a hallmark of NF-kB-mediated transcription. Interestingly, 
the activation of this TRAIL receptor leads to the upregulation of c-Fos pro-oncogenic gene 
(Siegmund et al., 2001), which is highly expressed by endothelium infected exclusively by 
cytotoxic strains. Part of the extrinsic apoptotic pathway involves mitogen-activated protein 
kinases (MAPK) and the activation by reactive oxygen species (ROS). It seems that cytotoxic 
strains induce MAPK phosphorylation which, in turn, activate ATF3, JUN (Kappelmann et al., 
2014) and other transcription factors responsible for pro-apoptotic gene expression such as 
BCL3 (Amundson et al., 1999).  
The second possibility to induce endothelial apoptosis that could be exploited by 
cytotoxic S. aureus strains is the activation of the intrinsic apoptotic pathway. The intrinsic 
apoptotic pathway is tightly bound with the extrinsic pathway and has been reported to 
play a role in S. aureus-mediated HUVEC apoptosis. The intrinsic apoptotic pathway includes 
activation of BCL-protein family members, which compromise mitochondrion integrity upon 
apoptotic stimuli (Esen et al., 2001). The intrinsic pathway is also interconnected with the 
extrinsic through activated death receptors, ROS or MAPK kinases which can also activate 
BCL proteins (Cross et al., 2000). Activated BCL proteins activate caspase 3 through 
cytochrome-C release and induction of apoptosis-activating factor 1 (Apaf-1) (Dhanasekaran 
and Reddy, 2008). 
One of the central questions we looked to investigate was why infection with pro-
inflammatory isolate 8325-4 does not cause apoptosis in endothelium. We assume that non-
cytotoxic strain 8325-4 mainly activates cell death-related gene expression via IRF1 and 
STAT1 transcription due to intracellular bacteria degradation and presentation of DNA/RNA 
to intracellular receptors of the interferon signaling pathway such as TLR 3 and 9 or RIG-I.  
To begin, this assumption can be partially proven by the observed overexpression of 
TRAIL, INDO, BATF2 and Poly (ADP-Ribose) Polymerase (PARPs) genes by 8325-4 strain (Fig. 
45).  These genes belong to the group of interferon-inducible genes and are regulated by 
IRF1 and STAT1 transcription factors (Gong and Almasan, 2000; Ma et al., 2011; Juszczynski 
et al., 2006). In addition, the strain 8325-4 demonstrated intracellular persistence more so 
than intracellular growth. This may implicate impaired growth due to the possible 
destruction by activated endothelium. 
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As such, we speculate that the expression of cell death-related genes by 8325-4 strains 
through the interferon signaling pathway cannot lead to endothelium apoptosis, most likely 
due to the need for additional pro-apoptotic stimuli.  For instance, TRAIL ligand, whose 
expression is highly upregulated by the 8325-4 strain, was shown to play a role in the 
extrinsic apoptotic pathway. However, its primary induction does not lead to apoptosis in 
every cell type. For certain cell types, it was shown that the additional activation of the 
intrinsic apoptotic pathway is needed to induce apoptosis (Almasan and Ashkenazi, 2003). 
Moreover, it was demonstrated that TRAIL-induced HUVEC apoptosis is regulated by surface 
expression of TRAIL-R3 receptor (Zhang et al., 2000). This means that a significant increase 
in apoptosis could occur, but only upon removal of TRAIL-R3 from the HUVEC surface TRAIL 
ligand (Zhang et al., 2000). Therefore, TRAIL stimulation requires additional stimuli in order 
to induce apoptosis in endothelium. 
Other receptors such as TLR4, TLR3, NOD2 and RIG-I can also recognize staphylococcal 
determinants and are likely able to modulate NF-kB, CREB1 or STAT1 activation as well as 
play a role in endothelium defense response (Takeuchi et al., 1999; Kato et al., 2011). 
 
4.4. Verification of the role of protein kinases phosphorylation in S. 
aureus-induced endothelial apoptosis 
To verify the role of the extrinsic apoptotic pathway in endothelial cell death induction 
we performed a kinase inhibition assay. The selection of kinases was based on previous 
studies where S. aureus’ ability to modulate phosphorylation/de-phosphorylation events in 
MAPK pathway was demonstrated, which had a very significant impact on the cellular 
response to infection. In particular, staphylococcal peptidoglycan-induced activation of TLR2 
was shown to activate such regulatory kinases as p38 and JNK MAPK (Into and Shibata, 
2005; Esen et al., 2001). JNK, p38 and ERK ½ MAPK signaling is a complex process which has 
also been shown to involve a number of other upstream regulatory kinases such as PKC, 
PI3K and ASK1 (Fukao and Koyasu, 2003; Kappelmann et al., 2014).  Currently, the exact 
mechanism of how kinase interplay affects apoptosis is not known, although it is 
hypothesized to occur through the regulation of certain transcription factors and cell death 
effectors (Cross et al., 2000).  
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During the experiment, JNK, PI3K, ERK 1/2, PKC, p38 and ASK1 were inhibited with 
commercially available selective inhibitors.  It was found that the inhibition of stress-
responsive kinase ASK1 and its downstream partner p38 allowed for the rescue of infected 
and hydrogen peroxide treated cells. This data confirms the previously described 
involvement of ASK1 and p38 in S. aureus-mediated cellular death, though the direct anti-
apoptotic effect of ASK1 and p38 inhibition for infected endothelium had not been 
previously described prior to this experiment.  
We hypothesize that cytotoxic strains of S. aureus induce endothelium apoptosis through 
a stronger activation of TLR 2 signaling and/or higher ROS production to activate caspase-3-
mediated apoptosis via ASK1 and p38 MAPK signaling. This assumption is supported by the 
fact that ASK1 kinase plays an important role in cellular stress response and has been shown 
to be activated in the TLR 2 signaling cascade or by ROS. The downstream kinase p38 have 
been shown to be activated by and play a role in caspase-3-mediated apoptosis (Into and 
Shibata, 2005).  
By contrast, the role of PKC appeared to have an anti-apoptotic function. The effect of 
increased cell death upon PKC inhibition indicated an anti-apoptotic role of PKC signaling in 
infected endothelium and a possible involvement in the inhibition of ASK1-p38 signaling. 
Furthermore, PKC was shown to inhibit p38 phosphorylation in bovine leukocytes 
(Yamamori et al., 2000). 
Another member of MAPK ERK ½ can be activated by staphylococcal surface antigens 
challenging the PRRs (Ratner et al., 2001); however, this was not shown for infected 
endothelium. This MAPK has anti-apoptotic properties and can become activated through a 
similar pathway with p38 or JNK (Takeda et al., 2007). In our experiment, the inhibition of 
ERK ½ did not influence endothelium survival upon S. aureus infection which suggests it has 
a limited role in endothelium cell death regulation during staphylococcal infection. It seems 
that activated endothelial ERK ½ has a pro-apoptotic effect upon hydrogen peroxide 
treatment which indicates its “selectivity” in cell death regulation.    
The other regulatory kinase PI3K was shown to be involved in VEGF signaling in 
endothelium with strong anti-apoptotic functions. This has been demonstrated as, upon 
growth factor activation, PI3K mediates endothelial proliferation (Bullard et al., 2003). 
Additionally, PI3K has been shown to inhibit p38 and other MAPK phosphorylation (Fukao 
and Koyasu, 2003), which are features that might contribute to cell death prevention. As 
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expected, the endothelium inhibition of PI3K had a strong apoptotic effect irrespective to 
the applied treatment. This finding indicates the possible role of one more regulatory 
kinases in endothelial cell death prevention upon infection. Interestingly, co-regulation 
between PKC and PI3K kinases has already been shown (Cross et al., 2000), whose anti-
apoptotic effect during infection could be regulated synergically.  
Considering that JNK is activated by ASK1 in the same pathway as p38 and based on 
previous research suggesting its role in endothelium apoptosis (Esen et al., 2001), we 
expected that JNK inhibition would have an anti-apoptotic effect. Surprisingly, sustained 
endothelial JNK inhibition led to a state of 100% cellular death irrespective to the treatment 
applied. Therefore, the role of JNK kinase in cell death has to be elucidated by a different 
experimental approach.  
 
Figure 41. The model of endothelium apoptosis regulation by kinase signaling upon infection with cytotoxic S. 
aureus strains. Grey arrows represent literature data that was not tested in our study. 
 
In conclusion, we propose a model of kinase interaction in endothelium apoptotic 
regulation. The cytotoxic S. aureus strain can trigger surface receptor TLR 2 and induce ROS 
production. These changes lead to ASK1 and p38 MAPK activation and cell death induction 
through caspase-3 dependent mechanisms. PI3K and PKC regulatory kinases play a role in 
inhibiting ASK1-p38 phosphorylation and promoting cell survival. The role of JNK and ERK ½ 
kinases in this process is not clear and should still be elucidated. Non-apoptotic strains 
cannot induce apoptotic changes, most likely due to the hypo-stimulation of TLR 2 and/or 
low ROS production with low or no ASK1/p38 activation (Fig. 41). 
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To summarize, we suspect that both the extrinsic and intrinsic apoptotic pathways are 
playing a role in endothelial cell death induced by cytotoxic S. aureus strains. However, the 
particular role of each pathway requires further clarification.  In this study, we attempted to 
explain the background of strain-specific S. aureus-induced apoptosis based on 
transcriptional data, apoptotic and kinase inhibition assays along with the data of strain-
specific S. aureus intracellular survival (Fig. 42). 
 
Figure 42. Hypothetical scheme of endothelium cell death induction by cytotoxic S. aureus strains. 
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Summary 
Staphylococcus aureus is a prominent, wide-spread human pathogen causing various 
clinical complications. S. aureus antibiotic resistance is currently a prevalent clinical problem 
that leads to an increased cost of treatment, duration of hospitalization and severe diseases. 
One of the complications during S. aureus treatment is the broad variation of strains each 
representing different virulence and pathogenic potentials which complicates predicting 
infection outcomes and choosing the right course of treatment to eradicate the pathogen. 
During many S. aureus-born life-threatening infections, interactions of the pathogen with 
endothelium is of critical importance. For this reason, this study focused on understanding 
strain-specific S. aureus-endothelium interactions as they are the key to better 
understanding S. aureus infection strategies and clarifying the specific endothelium 
regulation mechanisms at work during infection. We were especially interested in examining 
early endothelial response to strain-specific S. aureus infection. The early endothelial 
response is of great importance at the initial stage and overall success of the infection as 
well as for the situation of systemic endothelial response to a massive release of pathogen 
into the bloodstream.   
A number of studies have been performed to better understand how particular bacterial 
virulence factors influence systemic responses in endothelium. In particular, S. aureus 
adhesins facilitate adhesion of the pathogen to endothelium as well as, after uptake, 
provoking endothelium immune response accompanied by cell death induction. The 
immune response of endothelium leads to the activation of pro-inflammatory phenotypes 
and the gene expression of genes involved in immunity, cell death, cytokinesis and other cell 
functions.  
In this study we focused to uncover fundamental S. aureus-induced pathophysiological 
relevant mechanisms in endothelial cells in the early stages of infection. After screening 24 
septic isolates with respect to pro- and anti-inflammatory early responses in endothelium, 
we observed a wide heterogeneity. However, several strains were identified as exhibiting 
extreme behaviors just after infection. In particular, we found two strains with clear anti-
inflammatory properties and two strains with pro-inflammatory properties. Furthermore, 
three of these four strains induced cytotoxicity while one strain had no such effect. Some of 
the S. aureus strains showed strong anti-inflammatory effects, even upon TNF-α stimulation 
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while others did not alter TNF-α-induced endothelial response. We used these “extreme” 
strains for microarray analyses and found a tremendous differences in the gene expression 
patterns  in endothelium early after infection (7 hours). Each isolate changed the expression 
of a distinctive number of genes with specific levels of expression change. We propose that 
a number of differentially regulated genes and their level of differential expression are 
related to the specific virulence of a particular S. aureus isolate. The strain-specific 
endothelial gene expression analysis showed a probability to be promoted by a number of 
activated transcription factors likely activated through PRRs and interferon signaling 
pathways.  
The expression data was used to predict possible mechanisms and pathways involved in 
endothelium defense response, with the focus on cell death induction. We reported that S. 
aureus strains vary in their ability to cause endothelium cell death. We divided them into 
two groups of pro-apoptotic and non-apoptotic isolates. The pro-apoptotic isolates showed 
early apoptotic changes in Annexin V/PI assay and were shown to induce apoptosis by 
activation of caspase 3. We assumed that cytotoxic isolates of S. aureus are able to activate 
caspase 3 through TLR 2, TLR 4 signaling, and via reactive oxygen species production (ROS), 
due to intracellular multiplication and toxin-mediated mitochondria challenge.  
We suggested that strain-specific differences in apoptosis induction depend on variations 
in invasiveness, toxin production and intracellular growth between cytotoxic isolates. These 
differences partially determine strain-specific differential phosphorylation of apoptosis-
regulated kinase 1 (ASK1), p38, PI3K and PKC kinases, which regulate the process of 
endothelium cell death. 
There are still many questions left unanswered regarding the precise mechanisms of anti-
inflammatory properties and cytotoxic effects of S. aureus isolates. The particular S. aureus-
induced pathways responsible for apoptosis and gene expression induction need to be 
confirmed through molecular biology testing. 
 The results of this study will help deepen our understanding of the pathophysiological 
processes at work during S. aureus-endothelium interactions. Information concerning the 
mechanisms of interplay between pathogen virulence factors and the host defense 
response can be used to enhance targeted clinical diagnostics and development new non-
antibiotics therapies to improve treatment and slow the development of new resistant 
strains.  
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